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Resumo 
 
O uso de plantas transgénicas para a produção de proteínas recombinantes com interesse 
comercial e farmacêutico oferece várias vantagens quando comparado com os sistemas 
tradicionais. A utilização de sistemas de planta inteira tem potencial para estudos de tráfego de 
proteínas e o sistema de culturas em suspensão combina as vantagens da planta com os 
benefícios de produzir uma proteína recombinante em culturas celulares. 
 
Nesta tese de mestrado, foram utilizadas plantas Medicago truncatula expressando uma 
proteína humana do tipo lipocalina, prostaglandina D2 sintase (L-PGDS). Este estudo apresenta 
a primeira análise da produção desta proteína nesta planta específica e o primeiro estudo do 
tráfego subcelular desta proteína em plantas. Foram analisados dois sistemas de produção: 
sistemas de planta inteira e culturas em suspensão. A presença da L-PGDS foi estudada, 
através de Western Blotting e microscopia de fluorescência e electrónica, em três diferentes 
órgãos da planta (folha, raiz e semente) e nas células em suspensão e meio celular. 
 
A proteína L-PGDS mostrou acumular-se em diferentes locais e padrões consoante o tipo 
de célula em que estava a ser produzida. Trabalhos recentes têm demonstrado que a 
especialização funcional das células vegetais nos órgãos de armazenamento pode influenciar o 
tráfego subcelular das proteínas recombinantes, e assim, o destino da proteína pode ser 
diferente entre sementes e folhas da mesma planta transformada. Foi também demonstrado 
que a espécie de planta em estudo, onde a proteína recombinante é produzida, pode alterar os 
parâmetros de tráfego. 
 
A Medicago truncatula é, assim, um sistema promissor para a produção de proteínas 
recombinantes. Os resultados iniciais obtidos neste estudo poderão contribuir para estudos 
futuros e para o desenvolvimento de Molecular Farming. 
 
Palavras-chave: Molecular Farming, Medicago truncatula, L-PGDS, proteína recombinante, 
microscopia de fluorescência, microscopia electrónica. 
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Abstract 
 
The use of transgenic plants for the production of recombinant proteins with commercial 
and pharmaceutical value offers several advantages when compared to the standard systems. 
Whole plant systems have potential for studies of the recombinant protein trafficking and 
suspension cell cultures combine the advantages of plants with the benefits of protein 
production by cell cultures. 
In this master thesis work, Medicago truncatula plants expressing a lipocalin-type human 
prostaglandin D2 synthase (L-PGDS) were used and the protein trafficking was studied. This 
study was the first analysis of the production of this protein in this specific plant and the first 
study of the subcellular trafficking of this protein in plants. Two production systems were 
analyzed: whole-plant systems and suspension cell cultures. The presence of the L-PGDS was 
studied in three different plant organs (leaf, root and seed) and in the cells and cell medium, by 
Western Blotting and fluorescence and electron microscopy. 
 
The L-PGDS protein appeared to accumulate in different places and patterns depending 
on which type of cell it is being produced. Recent work has shown that functional specialization 
of plant cells in storage organs can influence the subcellular trafficking of recombinant proteins, 
so the protein subcellular fate could be different between seeds and leaves of the same 
transformed plant. It has also been demonstrated that the plant species where the recombinant 
protein is produced, can alter the trafficking parameters. 
 
Medicago truncatula is, thus, a promising system for the production of recombinant 
proteins. The initial results obtained in this study could contribute to future studies and 
development in Molecular Farming. 
 
Keywords: Molecular Farming, Medicago truncatula, L-PGDS, recombinant protein, 
fluorescence microscopy, electron microscopy 
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1 Introduction 
!
1.1 Molecular Farming 
!
Plants have been important to humans and human survival, from fruits and natural dyes to 
pharmaceuticals and materials such as cotton and sugar. In fact, human population has been 
choosing the better fruits, which look better and are not poisonous, for centuries. This process 
was an earlier version of genetic engineering, once the most interesting features of plants were 
chosen over others. Therefore, current plants do not look like the ones common centuries ago. 
Nowadays, the pharmaceutical field is important, once it is imperious to produce new and 
more effective compounds in a safer and inexpensive way, and plants offer several metabolites 
with many different therapeutic effects. Plants naturally develop these compounds, so they can 
protect themselves against pathogens and predators. There are compounds with several 
functions such as wound-healing, anti-inflammatory, antimicrobial or psychoactive properties 
(Boehm, 2007). 
In the 1980s, several improvements were achieved in the field of plant biotechnology, 
caused by the development of strategies and techniques that enabled the insertion of 
exogenous DNA in plants by infection with Agrobacterium tumefaciens, allowing heterologous 
protein production (Fraley et al., 1983). Hiatt and colleagues first reported the production of 
recombinant antibodies in plants in 1989. They demonstrated that functional antibodies could be 
produced and assembled in transgenic tobacco leaves (Hiatt et al., 1989). With these advances, 
large-scale production of proteins was achieved and named “Molecular Farming”, as it allows 
the production of important and commercially valuable proteins in plants (Fischer & Emans, 
2000; Schillberg et al., 2003). 
Molecular Farming presents an alternative to other existing processes, since it offers 
several advantages such as economic benefits (growing a plant is more economical in material 
and personnel than settling a fermentation or a bioreactor system), safety (plant production 
reduces health risks from pathogen contamination, for it does not contain human or animal 
pathogens) and storage benefits (it is easier to store a small plant seed, which as a plant will 
produce the desired protein, and seeds remain stable at ambient temperatures for months or 
even years) (Giddings, 2001; Schillberg et al., 2003). Furthermore, plants can also perform 
post-translational modifications needed to obtain a correct protein biological activity. For all 
these reasons and advantages plants are now seen as a new source of molecular medicines 
and other products of commercial interest. 
Plants are expected to achieve a higher economic benefit than other production systems 
because they have greater capacities of storage flexibility and scalability and the production 
costs are lower, when compared with most of the systems used nowadays. Thus, once the 
investment is made, the return will be higher. 
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Along with consecutive developments in this area of study, several methods to produce 
recombinant proteins in plants appeared in plant sciences. There are two main strategies to 
express a recombinant protein in a plant: transient expression and stably transformed plants. 
The first strategy allows the production of the recombinant protein without the permanent 
transformation of the plant cell genome and, therefore, has the advantage of not resulting in 
transgenic plants, which carry several ecologic and regulatory concerns, and has proven to be 
successful for rapid, small and medium-scale production. It can be used to test the function of 
an expression construct before proceeding to transform the plant cell genome permanently and 
eventually to a large-scale production. The latter one requires a longer time for generation and 
characterization of produced lines, as well as the generation of enough seed material (Boehm, 
2007; Abranches et al., 2005; Schillberg et al., 2003). 
The most frequent strategy is stable nuclear transformation, which requires transferring 
foreign genes into plant cells and then to incorporate them within the host nuclear genome, by 
infection with Agrobacterium tumefaciens or by particle bombardment. This way of stably 
transforming a plant is advantageous, since the seeds produced by this plant will also be 
transformed and, due to the high resistance of seeds and their capability of being stored without 
suffering degradation, it becomes easier to propagate the transformed plant (Abranches et al., 
2005).  
However, Molecular Farming systems also present some disadvantages. The most 
notorious is the difference in the glycosylation patterns between plants and mammals. This 
characteristic is of such importance, once it glycosylation patterns are one cause of immune 
responses in humans that research on this area is urgent so glycosylation pathways can be 
more clearly understood and needed pathway modifications can be applied in the future. 
Several strategies have been developed to solve this problem, such as directing the protein to a 
certain organelle in the cell or accumulating the protein in a specific organ (Boehm, 2007). This 
will be discussed later on. 
 
1.2 Molecular Farming Products 
!
For decades, several compounds have been produced such as vaccines, antibodies, 
biopharmaceutical proteins and industrial proteins. In 1986, Barta and collaborators made the 
first breakthrough in this research field when they achieved the expression of a gene encoding 
the human growth hormone in plants (Barta et al., 1986). Hiatt and colleagues also brought 
novelty in this field, once they assessed plants as a cost-effective bioreactor to produce 
antibodies of different types (Hiatt et al., 1989; Hiatt et al., 1990). 
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1.2.1 Vaccines 
 
Charles Arntzen first foresaw plant vaccines or edible vaccines in the early 1990s, and 
since then this topic became an important field of Molecular Farming research (Mason et al., 
1992). Plant vaccines are a novel system of delivery because the vaccine itself is produced by 
the plant and accumulated in the fruits or the seeds. This progress simplifies the delivery and 
the administration of the vaccine, besides reducing the production costs. The delivery is 
simplified since sophisticated refrigeration systems are not needed, allowing an easier 
transportation and storage. Production costs are lower and there is no need of purification steps 
since the fruit or seed is orally administrated. For this purpose the choice of a plant species like 
banana or some other fruit is important, since the plant has to have an edible part that can be 
eaten by humans or animals without cooking or any kind of processing. The major concern with 
edible vaccines is the degradation of protein components in the stomach and gut before they 
promote an immune response. In 1998, Mason and colleagues suggested an alternative 
processing when they tested a possible vaccine against enterotoxigenic strains of Escherichia 
coli. The vaccines consisted in subunit B of the heat-labile toxin (Lt-B), expressed in corn. They 
suggested that a typical 1 mg dose of Lt-B would be delivered in the embryo fraction 
(decreasing the dose volume) or in a cooked whole corn snack (increasing palatability). The 
final conclusion was that neither treatment degraded the antigen and its biological function 
remained stable (Mason et al., 1998). Thus, plant vaccines are a promising field of research 
since it seems a safer and cost-effective way to achieve mass immunization compared to other 
systems (Boehm, 2007; Daniell et al., 2001). 
 
1.2.2 Antibodies 
 
Antibodies are an important tool for the diagnosis and treatment of several diseases and 
thus a promising field of research. Recombinant antibodies with the same biological activity than 
antibodies produced by other systems have shown to reduce immunogenic reactions. In 
addition, functional recombinant antibodies have been successfully produced in plants and 
stored in plant leaves and seeds. This shows the potential of long-term storage of protein and 
the reliability of this production system (Kaiser, 2008; Giddings, 2001; Boehm, 2007). 
 
1.2.3 Biopharmaceutical proteins 
 
One of the greatest breakthroughs in recent years was the production of a Gaucher’s 
disease therapeutical protein. In 2007, Shaaltiel and colleagues discovered a way of producing, 
at a large scale, human recombinant glucocerebrosidase in carrot cell cultures (Shaaltiel et al., 
2007). Nowadays, Protalix, an Israeli company, is producing this recombinant protein in plastic 
bag reactors with transgenic carrot cell cultures. This way of producing this compound reduces 
the production costs compared with mammalian expressing systems (Kaiser, 2008). 
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Despite all advantages of plant systems, biopharmaceutical protein production gives rise to 
some concerns such as transgenic crops affecting food supply by contamination of the non-
transgenic crops. There is also a limitation in the level of recombinant proteins produced in 
transgenic plants, since the common values obtained are less than 1% of the total soluble 
protein needed for commercial feasibility. Another concern is the possibility of human 
immunoreactions after administration. This problem can be solved by humanizing the plant, as 
will be explained later. So, plant-derived pharmaceuticals have to meet high standards of safety 
and performance for production to become cost-effective (Boehm, 2007; Daniell et al., 2001). 
 
1.2.4 Industrial Proteins 
 
Industrial proteins are also an important product of Molecular Farming since it is a cheaper 
way of producing these compounds. In 1997, Chong and colleagues have achieved the 
expression of recombinant human milk protein β-casein in transgenic potato plants (Chong et 
al., 1997) and in 2002, Nandi and collaborators expressed human lactoferrin in transgenic rice 
seeds (Nandi et al., 2002). These two proteins are examples of industrial applications of 
proteins produced in plants, in this case for infant formulas and baby foods. Other kinds of 
proteins are also being produced by this system such as amylases, phytases and hydrolases 
(see Table 1.2.4.1). Molecular Farming will be improved when high levels of expression can be 
achieved, as this affects the production costs and, thus, the investment. In any case, this way of 
producing industrial proteins has much more room for improvement than other systems already 
established (Horn et al., 2004). 
 
Table 1.2.4.1 – Biopharmaceuticals for human health produced in transgenic plants (Daniell et al., 2001). 
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1.3 Molecular Farming Biosafety 
!
Most recombinant proteins produced in mammals or bacteria present several contaminants, 
which are absent in plants, a feature that makes plant systems particularly suitable for 
production of therapeutical proteins, vaccines and other important recombinant proteins. Thus, 
plant systems are particularly suitable for production of therapeutical proteins, vaccines and 
other important recombinant proteins. However, plants present also some disadvantages such 
as the presence of contaminants like pesticides and transgene pollution, causing environmental 
safety concerns that must be addressed. The use of transgenic plants in Molecular Farming 
raises the concern of contamination of non-transformed crops or of the environment while 
harvesting, transport and processing takes place. Another matter, not less important, is that all 
recombinant proteins produced in plants to be administered in humans must be compared to 
their native counterparts and undergo several safety tests. Transference of transgenes to non-
transgenic plants can be prevented by elimination of marker genes or superfluous sequences or 
by physical or genetic containment, removing the source of pollution (Commandeur et al., 
2003). 
 
1.4 The Choice of the Farming System 
!
The choice of the farming system requires some tests and several prerequisites to ensure 
that the chosen system presents optimal conditions for the production of the specific protein and 
its final application. One important concern is to ensure and establish high yields of the 
recombinant protein to make the production system cost-effective. Another concern is to 
guarantee the stability of gene expression over generations, ensuring the continuous production 
of the recombinant protein without the need of another transformation. Protein accumulation 
must be the next step to analyze, since protein accumulation in certain cell compartments has 
shown to promote higher yields (Conrad & Fiedler, 1998). So, the choice of the production 
system must be decided on a case-by-case basis, depending on the protein to be produced, the 
planned product characteristics and its final use. Thus, for a system to be effective it has to 
meet good product yield functionality and good product homogeneity, as well as the post-
translational modifications. For this reason, the success of the production system depends on a 
clear understanding of cellular pathways and mechanisms for each plant species and for tissue-
specific factors that will affect protein expression, and therefore its quality and accumulation 
(Abranches et al., 2005). 
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1.5 The Plant Medicago truncatula 
!
Medicago truncatula belongs to the Fabaceae family, is original from the Mediterranean 
basin and is found in a wide range of habitats. It is also used as stock feed in leys or permanent 
pastures of the subtropical areas of Australia and the USA (Djemel et al., 2005; Maureira-Butler 
et al., 2008). 
Medicago truncatula was established as a model plant for the legume family (Cook et al., 
1997; Cook, 1999) and it shows several conserved genome regions with alfalfa and pea, it is a 
diploid autogamous species, it has a short genome and life cycle, and is easy to manipulate and 
transform in laboratory (Djemel et al., 2005). The phylogenetic distance to economically 
important crops is crucial in the choice of this plant by many researchers and by funding 
agencies, since it allows comparative genetic studies within the legume family. Besides, high 
levels of expression of a model recombinant protein have been observed in transgenic 
Medicago truncatula (Abranches et al., 2005). Such high levels of expression allow transgenic 
plants to be cost-efficient to maintain in vitro and easy to propagate under sterile conditions. 
The legume family is one of the most important groups of plants, since it provides several 
products necessary worldwide, as food for animals and humans, oil and available nitrogen 
(Abranches et al., 2005; Ané et al., 2008).  
 
1.6 Post-translational Modifications and Subcellular Deposition 
!
Most mammalian proteins have to undergo several post-translational modifications to be 
functional including proteolytic cleavage, addition of glycan chains, phosphorylation, 
hydroxylation or acetylation (Abranches et al., 2005; Gomord & Faye, 2004). 
The first methods used to produce recombinant proteins, especially for pharmaceutical 
purposes were bacterial fermentation (Escherichia coli), yeast cell cultures (Saccharomyces 
cerevisiae, Pichia pastoris) and mammalian cell cultures. Bacterial systems are known for their 
simplicity in manipulation and scaling-up although they also present setbacks such as not being 
able to fold proteins correctly, since the glycosylation process is absent, and the occurrence of 
protein accumulation and aggregation. Yeasts systems, on the other hand, can carry out 
glycosylation, even though the N-glycan chains are very different between yeasts and 
mammals. In addition, this kind of system presents a high rate of product loss. As for 
mammalian cell cultures, they are very complex and sophisticated because they mimic the 
protein production in the human body, reproducing the post-translational modifications almost 
perfectly. However, these cultures present high production costs due to the expensive 
infrastructure and material. They are also very difficult to scale-up because the reactor volume 
limits the process. Besides, mammalian systems present the risk of contamination with 
pathogenic organisms, such as viruses and prions, as well as oncogenic DNA sequences 
(Schillberg et al., 2003). 
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Protein glycosylation is the process that consists in covalently linking a sugar moiety, or 
glycan, to a protein, thus being an essential process of the post-translational modifications. 
Glycans can take various forms and can be linked to proteins in several ways. Therefore, plant 
glycoprotein modifications are of special interest as plants are a possible system for the 
production of compounds like pharmaceuticals and feed additives that are usually glycosylated. 
Since N-glycosylation is so essential for a good protein functionality and stability, the analysis of 
this process is of extreme importance when dealing with recombinant protein production 
(Abranches et al., 2005). 
One of the main advantages of transgenic plants over the production systems based on 
yeast or bacteria is their ability to accomplish most of the post-translational modifications 
needed for the bioactivity of recombinant proteins. Other production systems present several 
disadvantages. For instance, bacteria cannot carry out important post-translational 
modifications such as signal peptide cleavage, protein folding or disulfide bond formation. In 
contrast, plants perform the majority of the post-translational modifications required for a protein 
to be biologically active. The attachment of carbohydrates to the protein backbone affects 
several physicochemical properties, such as resistance to thermal denaturation, protection from 
proteolytic degradation, half-life, solubility and even alters crucial biological functions (Gomord & 
Faye, 2004). 
In plants, N-glycosylation occurs preferentially to O-glycosylation (when the sugar is 
attached to the hydroxyl end of Thr or Ser residues in the peptide backbone) and starts in the 
endoplasmic reticulum (ER). Here, a co-translational transfer of an oligosaccharide precursor, 
Glc3Man9GlcNAc2, to a specific asparagine residue in the N-glycosylation sequence Asn-X-Ser 
occurs (being X any amino acid except proline). After being transferred to the nascent protein 
and while the new glycoprotein is transported along the secretory pathway, the oligosaccharide 
N-linked to Asn undergoes maturation steps like the removal of glucose and mannose residues 
to form high mannose-type glycans and the addition of new sugar residues in the ER and Golgi 
apparatus, thus generating complex-type N-glycans. There are four different types of N-glycans 
that can be generated due to the substitutions of the common core (Man3GlcNAc2): high-
mannose type, complex type, paucimannosidic type and hybrid type (Figure 1.6.1) (Gomord & 
Faye, 2004; Saint-Jore-Dupas et al., 2007; Rayon et al., 1998). 
High-mannose type glycans from Man5GlcNAc2 to Man9GlcNAc2 are originated from the 
limited trimming of the glucose and mannose residues present in the precursor oligosaccharide 
Glc3Man9GlcNAc2. Complex type N-glycans result from the processing in the Golgi apparatus of 
high-mannose type N-glycans by the action of specific glycosidases and glycosyltransferases. 
This type of glycans is characterized by the presence of α (1,3) fucose residue linked to the 
proximal N-acetyl glucosamine and/or by the presence of β (1,2) xylose residue linked to β-
mannose residues of the core. It is also characterized by having one β (1,2) N-
acetylglucosamine residue linked to α-mannose units. N-glycans containing α (1,4) fucose and 
β (1,3) galactose have been identified as being linked to N-acetylglucosamine terminal units. 
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These modifications result in sequences of Gal β1-3(Fuc α1-4)GlcNAc known as Lewisa. These 
structures have been previously found on cell surface glycoconjugates of several primates 
(Watkins, 1995 and Dupuy et al., 2002) and in secreted glycoproteins of Xenopus tropicalis 
(Guérardel et al., 2003). In contrast, Lewisa structures are widespread among plants (Fitchette 
et al., 1999; Wilson et al., 2001). The third type of N-glycans, paucimannosidic type, are 
oligosaccharides found in all plants that have only one α (1,3) fucose residue and/or one β (1,2) 
xylose residue linked, respectively, to the proximal GlcNAc and to β-mannose residues of the 
common core Man3GlcNAc2 or to the restricted core Man2GlcNAc2. This type of N-glycans 
arises from the elimination of the terminal antenna resulting in a truncated form of complex type 
N-glycans and can be considered as typical vacuolar-type N-glycans. The last type of N-
glycans, the hybrid type, results from processing the single branch of the α (1,3) mannose of the 
Man5GlcNAc2 intermediate, leading to oligosaccharides with α (1,3) fucose and/or β (1,2) xylose 
residues linked to GlcNAcMan5GlcNAc2 (Rayon et al., 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6.1 – Structure of plant N-glycans. A – common core of N-linked glycans; B – high-mannose-type 
N-glycans; C – complex type N-glycans; D – paucimannosidic type N-glycans (Rayon et al., 1998). 
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Figure 1.6.2 – Differences between plants and mammalian complex N-glycans (Gomord et al., 2005). 
 
 
Furthermore, N-glycan structures from plants differ from those found in mammalian (Figure 
1.6.2). As the high-mannose type N-glycans contain five to nine mannose residues and have 
the same structure in plants and mammalian glycoproteins, on the other hand, complex type N-
glycans are structurally different between these expression systems. In plants, β-mannose is 
substituted by a bisecting β (1,2) xylose that is not found in mammalian N-glycans, and the 
proximal N-actylglucosamine of the core is substituted by an α (1,3) (Lerouge et al., 1998). 
When concerning the terminal galactose and the sialic acid, plants and mammals also differ in 
this aspect, since plants lack the β (1,4) galactose and terminal α (2,6) N-acetyl neuraminic acid 
(a sialic acid) residues, that are often found in mammalians (Sturm et al., 1987). 
 
1.6.1 Glycosylation Optimization and Humanization 
 
Since glycosylation patterns of a recombinant protein produced in plant are often not totally 
the same as the original mammalian protein, strategies of humanization of the plants have been 
developed. Folding, stability and post-translational modifications of a given recombinant protein 
will be affected by targeting the protein to certain cell compartment, changing its accumulation 
pattern. Strategies to target the recombinant protein to a desired location are therefore an 
option that allows control of the final product.  
The addition of an N-terminal signal peptide will cause the co-translational import of the 
protein to the ER. Further addition of the tetrapeptide KDEL or HDEL (lysine/histidine, aspartic 
acid, glutamic acid, leucine) will retain the protein in the ER (Franken et al., 1994). KDEL/HDEL 
causes the protein, in the secretory pathway, to be retrieved from the Golgi apparatus and 
transported back to the ER, so it is not lost in the continuous flow of proteins to the plasma 
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membrane. The absence of any target signal will promote the accumulation of the recombinant 
protein in the cell apoplast (Abranches et al., 2008).  
Another possible strategy to achieve this objective is engineering glycosylation in plants, 
performing a knock-out of some specific genes, inhibiting Golgi glycosyltransferases plant 
specific, as they are responsible for N-glycan maturation (Schillberg et al., 2003; Gomord et al., 
2010; Saint-Jore-Dupas et al., 2007). Strasser and colleagues (2004) have generated mutants 
of the Arabidopsis thaliana plant with N-glycans of the complex type lacking a β (1,2)-linked 
xylose and a core α (1,3)-linked fucose (Strasser et al., 2004). Interference RNA also proved to 
be a valuable tool to knock-down β(1,2) xylosyltransferase and α(1,3) fucosyltransferase in 
Nicotiana benthamiana (which transfers a L-fucose sugar from a GDP-fucose to the GlcNAc 
core) (Strasser et al., 2008). Furthermore, it is possible to express heterologous 
glycosyltransferases to add sugar residues common in mammalian proteins. These enzymes 
can be targeted to a specific subcellular localization improving the knock-in strategies. It is also 
possible to glyco-engineer a plant to add sialic acid in a galactose residue, characteristic of 
human glycoprotein (Misaki et al., 2006; Paccalet et al., 2007; Castilho et al., 2010). The 
removal of the Lewisa epitope has to be taken into account because it will cause an 
immunogenic reaction in mammals (Gomord et al., 2010).  
Efforts in N-glycosylation engineering are concentrated on the combination of strategies that 
inhibit the biosynthesis of plant glyco-epitopes with complementation strategies, with the 
ultimate goal of obtaining fully humanized and sialylated N-glycans. Rapid progress towards 
humanization in plants is currently turning plant-engineered N-glycosylation to an advantage for 
this promising system. 
 
1.6.2 Localization vs. Glycosylation 
 
Since the enzymes that are responsible for the addition and modification of glycans are 
compartmentalized, the structure of N-glycans reflects the pathway, trafficking and deposition of 
the protein within the plant cell. Therefore, the glycosylation pattern of one protein can be 
controlled by trafficking and deposition. Thus, the final glycosylation pattern exhibited by a 
protein will reveal its pathway from its synthesis until its final destination. Several strategies can 
be applied to obtain a protein with the desired characteristics as explained in chapter 1.6.1. 
In the eukaryotic cells, for the polypeptides to be destined to the secretory pathway the 
cDNA construct has to contain a signal peptide that facilitates the transport to the ER. Then, 
proteins can be secreted to the cellular surface or to the endomembrane system. The 
subcellular fate and the pathway followed by the glycoprotein through the endomembrane 
system will determine the N-glycan final structure, since its core is modified by several 
glycosidases and glycosyltransferases (Rayon et al., 1998). 
It has been suggested that glycan modification could be influenced by several factors 
including plant species or even by the organ where the protein accumulates. So, if protein 
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glycosylation is dependent on its intracellular localization, differences in subcellular deposition 
can also occur between tissues, species and physiological stages (Abranches et al., 2005).  
Further evidence showed that the fate of a determined recombinant protein is intrinsically 
linked to the tissue where it is produced. Drakakaki and colleagues (2006) studied a transgenic 
rice plant transformed with phytase from Aspergillus niger and observed that the enzyme was 
secreted to the apoplast in the leaves and accumulated in the ER and in protein storage 
vacuoles in the endosperm cells. Thus, the phytase subcellular fate differed according to the 
type of tissue where it was being expressed (Drakakaki et al., 2006). 
Abranches and colleagues (2008) studied the same recombinant protein in another model 
plant, Medicago truncatula. They transformed the Medicago plant in two different ways: one 
cDNA construct with a signal peptide directing the protein to the secretory pathway (SP-phy) 
and one cDNA construct also with the signal peptide but with an additional KDEL signal for ER 
retention (KDEL-phy). In the SP-phy plant, phytase accumulated in the apoplast as expected. In 
KDEL-phy plant, the enzyme was detected in protein storage vacuoles and in the ER, as 
expected for a protein accumulating in the ER. This suggests that the final fate of a recombinant 
protein can be controlled by the addition of signals interpreted by the cell as an instruction to the 
subcellular targeting; which proves that each plant species behaves differently even thought the 
protein is the same (Abranches et al., 2008). Hence, this suggests that the functional 
specialization of plant organs influences the subcellular fate of a given protein. Arcalis and 
colleagues (2004) observed that recombinant phytase and human serum albumin produced in 
wheat seeds showed unexpected deposition patterns in the post-endoplasmic reticulum 
compartments suggesting that cereal seeds possess a more complex protein-sorting machinery 
than other plant tissues (Arcalis et al., 2004). 
Several intracellular locations have been tested for recombinant protein production, such as 
cytosol, ER, apoplastic space, vacuole and chloroplast (Boehm, 2007). ER gives rise to the 
highest yields of biologically active protein due to the fact that in this organelle proteins are 
more protected from degradation. In contrast, cytosolic expression leads to low levels of protein 
yield since proteases are present in the cytosol. Apoplastic expression also gives rise to good 
yields, since proteins also undergo modifications in ER and Golgi apparatus that mature and 
stabilize proteins (Boehm, 2007). 
 
1.7 Plant based platforms 
!
Leafy plants, like alfalfa and tobacco, are the ones that show a greater biomass yield, as 
they can be harvested several times a year. Nevertheless, leaf production has a disadvantage 
since these plants have to be kept in cold storage facilities or processed immediately at the 
harvesting site, summing additional costs. In contrast, seed crops, like cereals produce less 
biomass but provide excellent storage properties. When a transgene is expressed constitutively 
in the whole plant, the recombinant protein has to be extracted right after harvesting and protein 
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purification has to be performed, otherwise the protein will start to degrade as the plant organs 
start to decompose, except for the seed that can preserve its state for a good amount of time 
(Twyman et al., 2003). These steps represent additional costs in the final process, being simpler 
to target the recombinant protein to a storage organ like the seed, for instance. 
However, there are other strategies to obtain a good final product, like the fusion of the 
recombinant protein with oleosins (proteins within the oil bodies). If the recombinant protein is 
produced as a protein fused with oleosin (with a protease recognition site inserted between 
them), the final protein will accumulate in the oil bodies membrane, being easily purified by 
centrifugation. The oil droplets can be mixed with an aqueous medium and the oleosin cleaved 
from the protein of interest. A new centrifugation will result in two separation phases, where the 
aqueous medium will contain the recombinant protein (Hsieh & Huang, 2007). Another 
important technique is the use of an inducible promoter, which is also a good strategy to 
increase recombinant protein expression. A unique ethanol-inducible process was proposed by 
Werner and colleagues (2011). This is achieved by inducing, with ethanol, the release of viral 
RNA replicon leading to RNA amplification and high-level protein production (Werner et al., 
2011). 
Another strategy is the application of a unique transmembrane, as well as cytoplasmic tail 
sequences used as anchors to deliver recombinant proteins via distinct vesicular transport 
pathways, thus increasing the expression in vacuoles (Jiang & Sun, 2002). Strategies like the 
incorporation of an intron into the 5’ untranslated region of a gene, the choice of a terminator or 
even the coupling of a gene promoter with its cognate terminator can significantly influence the 
level of transgene expression (Dugdale et al., 1998; Mitsuhara et al., 1996; Outchkourov et al., 
2003). 
 
1.8 Plant Cell Cultures 
!
Plant cell cultures are an in vitro system that can be used for recombinant protein 
production under carefully controlled conditions (Figure 1.8.1). Haberlandt foresaw the theory 
for this system in 1902, when he established the plant cell totipotency concept (the ability of a 
single cell to divide and give rise to all the differentiated cells of an organism), being the cell the 
primary unit of all living organisms (Haberlandt, 1902). His work did not produce successful 
results but impelled future developments. 
Plant cell cultures have the potential to synthesize a variety of useful, low molecular weight 
molecules, present rapid production cycles and high levels of containment. This strategy of 
producing recombinant proteins uses cheaper medium components compared to the ones used 
in mammalian cell cultures and lacks human pathogenic particles. Notwithstanding, this 
methodology cannot compete with open field cultivation since production costs are higher, but 
still promise to be more cost-effective than mammalian cell cultures (Boehm, 2007). On the 
other hand, whole plant systems present several disadvantages when compared to plant cell 
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cultures: they present a longer development time, variations in product yield and quality, along 
with the difficulty in applying good manufacturing practices in the early steps of production 
(Boehm, 2007). In addition, in whole plant systems the possibility of contaminations with 
agrochemicals is present, cultivation conditions are variable, as well as the impact of pests and 
diseases. Additionally, this production system is intrinsically safe, since it is not infected with 
human pathogens or presents endotoxins. Moreover, maintaining this system is simple, 
because it uses a synthetic medium. This expression system is independent of climate, soil 
quality, season, day length and weather (Hellwig et al., 2004). 
Plant cell cultures can be initiated with a callus which is an undifferentiated tissue obtained 
by cultivating explants on solid medium with the appropriate mixture of plant hormones to 
promote and maintain the undifferentiated state. Transfer of viable calli to liquid medium and 
agitation on rotary shakers or in fermenters results in cultures of individualized cells or small 
aggregates of 10 to 20 cells. Alternatively, wild-type cell suspensions can be transformed with 
recombinant plasmids either by co-cultivation with Agrobacterium tumefaciens, electroporation 
of protoplasts, viral vectors or by particle bombardment. Several systems can be used for 
cultivation of plant cells such as hairy roots, immobilized cells and free cell suspensions, being 
the last one more suitable for large scale production in the biotechnology industry. It is possible 
to apply the common fermenter system to plant cell cultures with little adjustments and use 
standard modes such as batch, fed-batch, perfusion and continuous fermentation (Fischer et 
al., 1999; Hellwig et al., 2004). 
Recombinant proteins expressed in this system are, thus, found in the culture supernatant 
or retained within the cells. Protein localization will depend on two factors such as the presence 
of targeting leader peptides in the recombinant protein and the permeability of the cell wall for 
macromolecules. Generally, the cytosol is not suitable for protein storage due to the presence of 
proteases that can degrade it. Targeting signals can be a strategy to retain the recombinant 
proteins within certain cell compartments. However, this creates some complications when 
purifying the protein, since disruption of the cell is needed prior to protein purification. This 
process has several drawbacks such as needing additional equipment and labor, as well as 
causing the release of several substances such as proteases and phenolic compounds that can 
reduce the final protein yield. Therefore, the preferred method is to target the protein for 
secretion and capture it from the culture supernatant or release it from the cell with mild 
enzymatic cell wall digestion (Schillberg et al., 2003). 
However, plant cell cultures also have some limitations like poor growth rates, somaclonal 
variation (chromosomal rearrangements are an important source of these variations; common in 
plant cell cultures generated by calli) and gene silencing, together with inhibition of product 
formation at high cell densities, formation of aggregates and wall growth as well as shear-
sensitivity for some species (Fischer et al., 1999; Hellwig et al., 2004). Pires and colleagues 
(2008) have shown that a Medicago truncatula suspension cell culture transformed with the 
fungal enzyme phytase was easy to set up and that it was possible to obtain a high-level 
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production of the recombinant protein. They also recovered the recombinant protein easily, 
using different methods, and noticed that its activity was stable during the entire cell growth 
cycle (Pires et al., 2008). 
 
 
 
Figure 1.8.1 – How to obtain molecular farming products with transformed suspension cell cultures 
(Hellwig et al., 2004). 
 
 
The levels of expression and final product recovery in plant cell cultures are lower than the 
threshold where processes begin to be economically profitable. Separation of the plant cells 
from the fermentation supernatant is simple in comparison to bacterial fermentations and can be 
accomplished with several steps of filtration. In addition, some of the problems that arise from 
production of compounds by plant cell cultures in bioreactors can be solved optimizing the 
process, by improving bioreactor design and agitation conditions or by a better nutrient supply 
(Hellwig et al., 2004). Nowadays, BY2 cells and carrot cells are being used successfully to 
produce recombinant proteins. James and colleagues (2000) were able to produce a human 
granulocyte-macrophage colony-stimulating factor (a hemopoietic growth factor) in BY2 cell 
cultures (James et al., 2000). Shaaltiel and collaborators (2007) produced a recombinant 
glucocerebrosidase using carrot cell cultures (Shaaltiel et al., 2007). So, suspension cell 
cultures seem to have a great potential as a viable system for large-scale protein production. 
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1.9 From Plants and Cell Cultures to the Final Product 
!
Downstream processing is an integral part of every biomanufacturing process and it 
concerns the isolation and purification of the product from the raw biomass. Several aspects of 
downstream processing have to be customized specifically for whole-plant systems, including 
adding steps for the removal of fibers, oils and other by-products, along with optimizing process 
for the treatment of different plant species and tissues. 
Nonetheless, such issues do not apply so much to plant cell cultures, where the main 
choice is between the extraction of proteins from the wet biomass and purification of secreted 
proteins directly from the culture medium. Secreted proteins are advantageous since they avoid 
several unit operations during the purification process and provide a starting material, the 
culture supernatant, which has a much lower content of contaminating proteins and other 
metabolites than whole cell extracts. The downside of this approach is that the recombinant 
protein is highly diluted, so large volumes of liquid must be processed, and that the proteins can 
undergo significant degradation (Hellwig et al., 2004). However, when the protein is retained 
within a cell compartment or in the cytosol, a method suitable for cell disruption has to be 
applied. Mechanical cell disruption, like bead mills, arise several problems such as heat 
generation, disruption of cell compartments, liberation of noxious chemicals and generation of 
cell debris, which can be difficult to remove (Hellwig et al., 2004; Pires et al., 2008).  
Another strategy to purify the recombinant protein, in whole plant systems or suspension 
cell cultures is to fuse a tag (for example polyhistidine) to the recombinant protein as it will allow 
the retention of the protein on purification columns specific for this tag (Hellwig et al., 2004; 
Schillberg et al., 2003). 
The use of plants and cell cultures is still a growing process for the production of 
recombinant proteins. 
 
1.10 Prostaglandin D2 Synthase Lipocalin-type Protein 
!
Prostaglandin D synthase (PGDS) catalyzes the isomerization of the 9,11-endoperoxide 
group of PGH2, a common precursor of various prostanoids, to produce PGD2 with 9-hydroxi 
and 11-keto groups, in the presence of sulfhydryl compounds (Figure 1.10.1). This protein is a 
glycosylated human protein that is produced in a variety of tissues and is involved in several 
physiological and pathological functions. PGDS is a protein derived from the brain, being more 
abundant in the cerebrospinal fluid. PGD2 can act as a potent endogenous somnogen (sleep 
inducer), nociceptive modulator (pain regulator), anti-coagulant, vasodilator, broncho-constrictor 
and as well as an allergic and inflammatory mediator released from mast cells. PGDS can also 
transport non-substrate small lipophilic molecules (Urade & Hayaishi, 2000). 
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Figure 1.10.1 – Catalytic reaction by L-PGDS (Urade & Hayaishi, 2000). 
 
 
Two different types of PGDS have been purified and characterized: one is the lipocalin-type 
(L-PGDS), which was previously known as the brain-type enzyme or glutathione (GSH)-
independent enzyme, and the other is the hematopoietic PGDS, the spleen-type enzyme or 
GSH-requiring enzyme. These two types are different from each other in terms of catalytic 
properties, amino acid sequence, tertiary structure, evolutionary origin, gene structure, 
chromosomal localization, cellular localization, tissue distribution and also functional relevance. 
Besides, L-PGDS is the first member of the lipocalin family to be recognized as an enzyme and 
a highly glycosylated protein. Furthermore, it shares the characteristic as lipocalin, since it is 
secreted into various body fluids and binds small lipophilic-ligands (Urade & Eguchi, 2002). 
 
1.10.1 L-PGDS Enzymatic properties 
 
L-PGDS, first referred as β-trace, was discovered in 1961 by Clausen and identified as a 
major protein in the cerebrospinal fluid (CSF) (Clausen, 1961). When β-trace was identified as 
L-PGDS, the enzyme was purified from different body fluids, such as CSF and seminal plasma 
of humans and several mammals (Zahn et al., 1993). 
L-PGDS is known nowadays as an N-glycosylated monomeric protein with molecular weight 
of 20-31 kDa, depending on the size of the glycosyl moiety. The enzyme carbohydrate 
structures differ between various fluids. 
This enzyme requires free sulphydryl compounds (GSH, β-mercaptoethanol, cysteine) for 
the reaction. Besides, it is inactivated by chemical modification of an active thiol group, Cys65, 
with iodocetamide or N-ethylmaleimide, and is inhibited by inorganic selenium compound and 
several non-substrate hydrophobic ligands such as fatty acids, retinoids, biliverdin and bilirubin. 
L-PGDS is a very stable enzyme and is highly resistant against heat treatment and protease 
digestion. However, it is easily inactivated by enzymatic reaction, probably due to oxidation of 
the active site during the catalytic reaction. Urade and Hayaishi (2000) suggested that L-PGDS 
is a multiple function protein, as it acts as a PGD2-producing enzyme within the cell, as well as 
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functioning as a lipophilic ligand-binding protein after secretion into the extracellular space and 
various body fluids, although the endogenous ligands have not yet been identified (Urade & 
Hayaishi, 2000). 
 
1.10.2 L-PGDS Tertiary Structure 
 
Three enzyme cysteine residues, Cys65, Cys89 and Cys186 are conserved among all species. 
The last two cysteines form a disulfide bridge, which is highly conserved among most lipocalins. 
On the other hand, Cys65 is unique to L-PGDS as it has never has been found in other lipocalins 
(Figure 1.10.2.1). The replacement of this cysteine with serine or alanine by site-directed 
mutagenesis led to complete loss of the catalytic activity of the recombinant rat, human, mouse 
and frog enzymes, indicating that this cysteine residue is the key residue for the reaction 
catalyzed by L-PGDS.  
 
 
 
Figure 1.10.2.1 – Crystallographic structure of L-PGDS shown as a ribbon model (Urade & Hayaishi, 
2000). 
 
 
This enzyme is mainly composed by β-barrels with two sets of four-stranded anti-parallel β-
sheets and a three-turn α-helix. Cys65 is located in a hydrophilic pocket with enough size to bind 
retinoids, biliverdin, bilirubin and thyroid hormones. This enzyme possesses a β-barrel structure 
with a hydrophobic pocket and, in fact, the active thiol of Cys65, the active site for the catalytic 
reaction, faced the inside of the pocket (Urade & Hayaishi, 2000). 
 
1.10.3 L-PGDS Glycosylation 
 
L-PGDS is a glycoprotein, which presents two N-glycosylation sites, Asn29 and Asn56. The 
structure variations in these glycosidic chains generate different isoforms modified by post-
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translational processes (Lescuyer et al., 2005). Hoffman and colleagues (1994) determined  that 
all glycans were of the complex type and most (90%) of them were biantennary with no (40%), 
one (40%) or two (20%) N-acetylneuraminic acid residues. The 10% left were triantennary 
chains or biantennary chains with intact or truncated lactosamine repeats (Hoffman et al., 
1994). 
Lescuyer and colleagues suggested that the ratio of basic and acidic forms of the enzyme is 
higher in Alzheimer and Parkinson patients. Acidic forms are more glycolysed, suspecting that 
the disease’s degenerative process is associated with a deglycosylation of the protein 
(Lescuyer et al., 2005). 
 
1.10.4 L-PGDS Tissue and Subcelular Localization 
 
Urade and Hayaishi determined L-PGDS tissue distribution and cellular localization in 
humans in 2000. They concluded that this enzyme is localized in the central nervous system 
and related organs, like the cochlea (inner ear constituent) and ocular tissues, in the male 
genital organs and heart. The enzyme produced in these organs is secreted to several body 
fluids, such as CSF, eye fluids, seminal plasma and plasma (Urade & Hayaishi, 2000). L-PGDS 
is localized in different cell types of several human organs, such as oligodendrocytes and 
neurons in the brain and spinal cord, marginal and basal cells of Resser’s membrane in the 
cochlea, pigmented epithelial cells in the retina, as well as myocardial cells and endocardial 
cells in the heart (Lescuyer, et al., 2005; Ragolia et al., 2007). 
Lescuyer and collaborators showed that alteration of the PGDS post-translational 
modification pattern in cerebrospinal fluid may be involved in some neurological disorders 
associated with neurodegeneration. They also hypothesized that PGDS deglycosylation may be 
associated with cell death, inflammation, altered blood-brain barrier, all of which known to occur 
in most central nervous system conditions. 
 
1.11 Objectives 
!
Since Molecular Farming is an important field to develop, several researchers are 
committed to improving recombinant protein production. Although this field is substantially 
developed, there are several aspects related with protein intracellular trafficking that are not well 
established yet. Consequently, studying and understanding the secretory pathway in plants is 
important to identify basic cellular processes, as well as to improve the use of plants for 
recombinant protein production. Our laboratory transformed Medicago truncatula plants with 
prostaglandin D2 synthase cDNA in order to test this plant system for the production of human 
recombinant proteins. In this project, we aim to characterize the deposition patterns of this 
recombinant protein in different organs of the plant, as functional specialization of plant cells 
can affect the subcellular destiny of the protein (Abranches et al., 2008). To achieve this we 
analyzed the protein expression in three different plant organs (leaf, root and seed) by Western 
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Blot analysis and we studied the recombinant protein subcellular localization by 
immunodetection using fluorescence and electron microscopy. We also aimed to understand 
which system (whole plants vs. cell suspension cultures) is more suitable for the production of 
L-PGDS recombinant proteins. 
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2 Materials and Methods 
2.1 Plant Material 
!
Medicago truncatula cv Jemalong embryogenic line M9-10a (Neves et al., 1999) plants had 
been previously transformed in the laboratory using Agrobacterium mediated transformation 
with the pTRA-BT-AH plasmid. Transgenic seeds were available to be germinated and selected 
with the antibiotic kanamycin. 
 
 
 
Figure 2.1.1 – pTRA-BT-AH (L-PGDS) plasmid. 
 
 
 
 
Figure 2.1.2 – L-PGDS T-DNA. 
 
 
The T-DNA inserted in the plasmid, delimited by a right and a left border (RB and LB), 
contains the cDNA, which codifies L-PGDS protein. This cDNA is under the control of 35SS 
constitutive promoter (P35SS). Upstream of the cDNA is present a region that is non-translated 
and stabilizes messenger RNA (CHS), and also a murine leader peptide (LPH), optimized for 
plants, that directs the protein to the plant secretory pathway. Downstream of the L-PGDS gene 
is a fusion tag linked to the C-terminal with six residues of histidine (His 6) for protein 
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purification and a terminator sequence (35ST). There are also present MAR regions (Matrix 
Attachment Regions) that prevent gene silencing phenomena and stabilize the transgene 
expression. The cDNA also contains the kanamycin resistance cassette with the gene nptII, the 
promoter Pnos and the gene terminator PnosT. 
 
2.1.1 Seed Scarification, Sterilization and Germination 
 
The seeds need to be scarified to break the tegument. Sulfuric acid works well to achieve 
this step. This process is crucial to obtain a good yield of germination and it is also required to 
have a synchronized germination. Seeds were extracted from the pods and then placed in a 15 
mL tube. In the hotte, 5 mL of sulfuric acid were added to the tube, and the tube was manually 
inverted for 10 minutes. Then, the sulfuric acid was removed from the tube and 10 mL of sterile 
distilled water were added and the tube was stirred for 5 minutes, afterwards the water was 
discarded and this step was repeated three to five times. In a laminar flow chamber (Faster 
Bio48), Petri dishes were prepared with MS Medium (see chapter 6.1) and 0.2 M kanamycin 
(Duchefa) for selection of transgenic seeds. Ten to fifteen seeds were placed on the medium 
and incubated at 23ºC for three to five days, in a 16h light period chamber. 
 
2.1.2 Plant Transplanting and growth 
 
After germination, plants were transferred from the Petri dish to a pot with sterile soil with 
vermiculite, so that plant growth could be improved by airing the soil. Plants were watered and a 
plastic bottle was placed in the pot covering the plant, for protection. Plants were placed in a 
24ºC chamber with 16h light period. Plants were watered every other day. 
!
2.1.3 Establishment of suspension cell cultures 
 
Leaves from a transformed plant were removed and, for calli induction, wounded with a 
scalpel. Then, the wounded leaves were placed in Petri dishes with MS Agar culture medium 
(see chapter 6.1) with hormones (1mg/L of 2,4-D essential for plant body development, 1 mg/L 
of kinetin for cell division promotion and 10 mg/L of DTT to reduce disulfide bonds in the 
medium) and kept in a darkroom for a month. Calli were obtained at the end of this period. 
Then, calli were diced in small pieces and placed in an erlenmeyer with MS liquid culture 
medium with hormones. Cell cultures were left to grow in a rotative dark chamber (125 rpm) at 
23ºC. 
!
!
!
!
!
!
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2.2 Protein Analysis 
!
2.2.1 Protein Extraction from Medicago truncatula Plant Tissues 
 
Seed, Root and Leaf: 
Tissues were collected and weighted in an analytical balance (Sartorius Basic, Germany). 
Liquid nitrogen was added to a mortar, as well as the plant tissue. Samples were ground and 
the extraction buffer was added in 1:1 ratio (g of plant tissue: mL of extraction buffer). After 
thawing, the extraction buffer was mixed with plant tissue sample and transferred into several 
eppendorfs. Total protein extract was centrifuged (Biofuge 28RS, Heraeus Sepatech, Germany) 
at 22000 g for 20 minutes at 4ºC, the pellet was discarded and the supernatant was transferred 
to a new eppendorf. The supernatant was again centrifuged in the same conditions, the pellet 
was discarded and the supernatant obtained transferred to a new eppendorf and stored at -
20ºC. 
Cell culture: 
The vacuum filtration apparatus was assembled and filter paper (90 mm, qualitative medium 
speed; Labbox, Spain) weighted. The cell culture was filtered and the filter paper with filtered 
cells weighted again. The cell culture medium was stored at -20ºC. Then, filtered cells were 
removed from the filter paper with a spatula and transferred to a mortar with liquid nitrogen. 
Protein extraction procedures were the same as for root, leaf and seed. 
 
2.2.2 Sample Preparation for SDS – PAGE 
 
The samples were prepared in 1:4 ratio (µL of Sample Buffer 4x: µL of protein extraction 
sample; see chapter 6.1), span down at 16200 g for 10 seconds (Centrifuge 5415 D, Eppendorf, 
Germany) and then boiled at 100ºC for 10 minutes in a dry bath (AccuBlock Digital Dry Bath, 
Labnet International, Inc.). The final mixtures were then loaded in the SDS-PAGE gel, varying 
the load volume according to the tissue (20 µL for leaf, 15 µL for root and 25 µL for cells and 
cell medium). 
Sample concentration: 
Cell medium and root samples were concentrated with four volumes of absolute ethanol at  
-20ºC overnight. The mixture was then centrifuged (Biofuge 28RS, Heraeus Sepatech, 
Germany) for 10 minutes at 11200 g at 4ºC. After being dried with vacuum, the resulting pellet 
was resuspended with sample buffer 1x and boiled for 10 minutes at 100ºC in a dry bath. The 
samples were then centrifuged and loaded in a SDS-PAGE gel. 
 
2.2.3 SDS – PAGE Gel Preparation 
 
SDS–PAGE gel was prepared in a BioRad Mini-Protean 3 Cell Electrophoresis System 
(Bio-Rad, USA). The resolving gel solution (12,5% acrylamide) was prepared as described in 
the table below, mixed carefully and then applied between gel cassette glasses. Then, the total 
  Subcellular localization of recombinant proteins in plants 
24!
glass volume was filled with isopropanol as it prevents oxygen from getting in and inhibiting 
polymerization. The gel was left to polymerize for 1 hour and then isopropanol was removed 
with filter paper. The stacking gel solution was also prepared, as described below (table 1.3.1), 
added to the gel cassette, after which combs were placed between the glasses. The stacking 
gel allows sample alignment, which leads to the separation of sample proteins according to their 
electrophoretic mobility. After polymerization, the combs were removed. 
 
 
Table 2.2.3.1 – Preparation of Resolving and Stacking Gels. 
 
Solution 
Resolving Gel (mL) 
(12,5% acrylamide) 
Stacking Gel (mL) 
Total Volume 8.88 6.16 
Water 2.82 3.98 
Stacking gel buffer stock 
(see chapter 6.1) 
 1.25 
Resolving gel buffer stock 
(see chapter 6.1) 
1.25  
10% SDS (Duchefa 
Biochemie, Netherlands) 
0.1 0.05 
Acrylamide:Bisacrylamide 
(30:0,8) (Bio-Rad, USA) 
4.2 0.625 
TEMED (Sigma, USA) 0.005 0.005 
1,5% Ammonium 
Persulphate (Merck, USA) 
0.5 0.25 
 
 
The electrophoresis apparatus was assembled and running buffer was added until the 
electrodes were completely covered. Then, samples were loaded with a 50 µL syringe 
(Hamilton, Switzerland). 3 µL of Prestained SDS-PAGE Standards Low Range (Bio-Rad, USA) 
were also loaded in a separate lane. A 180 V and 30 mA (constant) electric field was applied to 
the apparatus for approximately 90 minutes. 
One gel was colored with Coomassie G-250 solution and the other one was destined to 
protein transfer. The first one was left to be colored with Coomassie G-250 overnight and in the 
next day the de-staining solution was applied to view the protein bands. 
 
2.2.4 Protein Transfer from SDS-PAGE gel to Nitrocellulose Membrane 
 
The protein transfer from SDS-PAGE gel to membrane was done using the semi-dry 
transfer method. The filter papers (BIO-RAD), nitrocellulose membrane (Hybond-C, 0.45 
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micron, Amersham) and gel were immersed in protein transfer buffer before protein transfer. 
The sandwich was assembled on a Trans-Blot SD (Semi-dry Transfer Cell, Bio-Rad) as shown 
in the scheme below. 200 mA with 16 V (constant) electric field was applied to the apparatus for 
25 minutes. 
 
 
 
 
 
 
 
Figure 2.2.4.1 – Semi-dry transfer assembling scheme. 
 
 
 
 
 
Figure 2.2.4.2 – Bio-Rad Trans-Blot SD Semi-Dry Transfer Cell. 
 
 
2.2.5 Protein Immunodetection 
 
After protein transfer from the acrylamide gel to a nitrocellulose membrane, the membrane 
was immersed in a blocking solution (3% BSA (Sigma, USA) and 5% skimmed milk powder 
(Nestlé, Switzerland) prepared in PBS-T; see chapter 6.1) for 1 hour at room temperature with 
gentle shaking (Duomax 1030, Heidolph, Germany). After this procedure, the membrane was 
washed three times, 5 minutes each, with PBS-T. The primary antibody (α L-PGDS, Abcam, 
Ab61866) was diluted at 1:200 with PBS-T, to a final concentration of 2µg/mL. The membrane 
was immersed in primary antibody solution, incubated for 1 hour at room temperature and then 
incubated overnight at 4ºC with gentle shaking. On the next day, the membrane was washed 
three times, 5 minutes each, with PBS-T. The secondary antibody (α rabbit, Sigma, A3687 
coupled to alkaline phosphatase) was diluted at 1:4000 with PBS-T. The membrane was 
immersed with the secondary antibody solution and incubated for 2 hours with gentle shaking at 
room temperature. In the next procedure, the membrane was washed three times, 5 minutes 
 
Filter paper 
 
SDS-PAGE Gel 
 
Membrane 
 
Filter paper 
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each, with PBS-T, followed by NBT/BCIP detection solution (see chapter 6.1). The membrane 
was placed on a glass plate and the detection solution was spread on it. The membrane was 
covered with a black box so light did not affect the reaction. The precipitate would become 
visible within a few minutes. 
 
 
2.3 Plant Tissue Preparation and Protein Immunodetection 
!
2.3.1 Microscopy slides Treatment with Poly-L-Lysine 
 
Glass slides with eight wells (Thermo Scientific, USA) were washed with a 2% Decon 
solution (Decon-9, Decon Laboratories Limited, United Kingdom) and bi-distilled water in a 1:50 
ratio. Slides and washing solution were placed in a coplin jar stirring for 2 h. Then, the slides 
were washed with bi-distilled water and air-dried. Poly-L-Lysine (Sigma-Aldrich, USA) solution 
was prepared in 1:10 ratio in bi-distilled water, so that 800 µL of solution could be placed on 
each slide, to ensure tissue and cell adherence. The solution was applied on the slides and left 
for 5 minutes. The poly-L-Lysine excess was then removed and the slides were left to dry 
overnight at room temperature. 
 
2.3.2 Medicago truncatula Plant Tissues Fixation 
 
Root and Seed Fixation: 
Root tips and seeds were fixed in 15 mL tubes with 4% paraformaldehyde (Merck, USA) 
fixation solution freshly prepared, stirring for 1h30 to 2h. The tissues were then washed 2 times 
for 10 minutes with TBS followed by bi-distilled water, so that TBS buffer salts can be removed. 
Leaf Fixation:!
Before the fixation process, leaves have to be discolored, since chlorophyll auto-
fluorescence interferes with the microscopy results. For this purpose, two ethanol (Panreac, 
Spain) solutions were prepared in bi-distilled water, one with 70% ethanol and the other with 
50% ethanol. The leaves were cut longitudinally in halves with a scalpel and added to 10 mL 
tubes with 70% ethanol solution. The plant tissue was incubated in a water bath (Grant GD100, 
United Kingdom) at 70ºC for 10 minutes. Then, the 70% ethanol solution was discarded and the 
50% ethanol solution was added to tubes, stirring on hand for 1 minute. 50% ethanol solution 
was then discarded and leaves were placed in distilled water to prevent dehydration (Erbs et al., 
2008). The leaf fixation procedure was the same as described for root fixation. 
!
2.3.3 Medicago truncatula Plant Tissue Section 
 
For this procedure, a vibratome (1000 plus Sectioning System, Vibratome, USA) was used 
and 30µm sections were cut. 
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Figure 2.3.3.1 – Vibratome 1000. 
 
 
Root Sections: 
Root tips were removed from tubes where fixation was performed and placed in a Petri dish. 
Then, tips were glued to a solid cube with super glue (Loctite, Henkel, Germany) and the set 
was placed on the tightened solid support. Then, water was added to the tray, covering the 
blade and the solid support. Speed and amplitude were set to 6,5 and 7,5 respectively. From 
controlling the direction control switch, the pause switch and the section thickness switch, root 
sections were obtained. The root sections were cut with 30 µm thickness. 
Leaf Sections: 
To obtain the leaf section, leaf halves (from fixation) had to be immobilized in 2,5% agar 
(Duchefa Biochemie, The Netherlands) cubes, by inserting the agar solution in a 
pharmaceutical blister packaging and then placing the leaf halves. The procedures were the 
same as for obtaining root sections, except for the speed parameter that was changed to 2. 
Seed Sections: 
Seed coats were removed with tweezers and the cotyledons were separated from each 
other, dividing the embryo in halves. The following procedures were the same as for root 
sections. 
 
2.3.4 Immunodetection of Recombinant L-PGDS in Suspension Cultured Cells by 
Fluorescence Microscopy 
 
1 mL of cell culture was transferred from an erlenmeyer to a test tube. Samples were 
centrifuged at 0,1 g for 10-15 minutes, the excess medium was removed, and at least 2x the 
cell volume of 4% paraformaldehyde were added. Then, the cells were left in the fixative, stirring 
for 1h. Samples were centrifuged again with the same parameters as before and the fixative 
was removed. Cells were rinsed gently by resuspension in PBS and then pelleted for removal of 
PBS. A couple of drops were placed onto poly-L-lysine treated slides and cells were allowed to 
settle for 10-15 minutes. The unbound cells were wicked away with a piece of paper towel. 2% 
Cellulase R10 in 1x TBS for 2 hours was applied to the sample. Slides were stirred in a coplin 
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jar with PBS solution for 10 minutes. After that, PBS excess was wicked away and blocking was 
performed by treating cells with 3% (w/v) BSA for 15 minutes. Then, slides were incubated with 
anti – L-PGDS antibody (2µg/mL) diluted in 3% (w/v) BSA in PBS 1x for at least 45 minutes at 
room temperature in a humid chamber. Then, slides were rinsed in fresh PBS for 15 minutes. 
PBS excess was wicked away and cells were treated with an appropriate secondary antibody 
anti-rabbit (40µg/mL) diluted in 3% (w/v) BSA in PBS 1x for at least 45 minutes at room 
temperature. Slides were rinsed in fresh PBS for 15 minutes. PBS excess was removed and 
DAPI was added and left for 5 minutes in a humid chamber. DAPI excess was removed and 
antifading mounting medium VectaShield (Vector Laboratories, Inc., USA) was added. A 
coverslip was applied, and then slides were sealed and kept at 4ºC (Paddock, 1999). 
 
2.3.5 Immunodetection of Recombinant L-PGDS in Root, Leaf and Seed by 
Fluorescence Microscopy 
 
2% Cellulase R10 (Duchefa Biochemie, The Netherlands) in 1x TBS were added to the 
slides and cell wall permeabilization was performed for 2 hours in a humid chamber since it 
allows the antibody access inside the cell. Slides were washed in a coplin jar with PBS for 10 
minutes, and the excess was removed from the slide wells. Then, primary antibody anti – L-
PGDS solution was prepared in 3% (w/v) BSA to a final ratio of 1:50 and, then, applied to the 
slides and blocking was performed for 45 minutes in a humid chamber. The slides were washed 
in fresh PBS three times for 5 minutes each. Then, secondary antibody was also prepared 
(40µg/mL) in 3% (w/v) BSA and applied to slide wells for 45 minutes, in a humid chamber. 
Slides were washed again with PBS three times, 5 minutes each, and then DAPI solution was 
applied to slide wells in a humid chamber for 5 minutes and excess removed with vacuum. 
Finally, antifading mounting medium Vectashield was applied to the slides. For visualization of 
the tissues and the protein deposition, three microscopes were used: Leica DMRB 
Fluorescence Microscope, Leica DM600B Fluorescence Microscope and Leica SP5 Confocal 
Microscope, Germany. For the first microscope, an UV lamp was used with N2.1 and A/DAPI 
filters and the camera used was Leica DFC 340 FX. For the second microscope, an UV lamp 
was also used with Texas Red and DAPI filter and the camera used was Andor Technology, 
model DU-885K-CSO-VP. For the confocal microscope, the lasers used were argon, DPSS 561 
and HeNe 633 and images were acquired with the confocal system Leica TSC SP5. Images 
obtained were treated with FIJI® program for Z and 3D projections and Adobe Photoshop CS® 
program for overlaying images. 
 
C 
!
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Figure 2.3.5.1 – Leica DMRB Fluorescence Microscope (A), Leica DM600B Fluorescence Microscope (B) 
and Leica SP5 Confocal Microscope (C). 
 
2.4 Immunodetection of Recombinant L-PGDS in Root, Leaf and Seed by Electron 
Microscopy 
!
2.4.1 Medicago truncatula Plant Tissue Fixation for Immunolocalization 
 
One 16% paraformaldehyde ampoule (Electron Microscopy Science, USA) was diluted in 
PBS 1x to reach the final concentration of 4% paraformaldehyde in PBS. Then, it was aliquoted 
in 1,5 mL eppendorf tubes and frozen at -20ºC. The tissue was placed in a Petri dish with 3 mL 
of fresh fixative and cut it small pieces. Then, with a brush, it was placed in an eppendorf with 
fresh fixative. When the samples did not settle at the bottom of the eppendorf, they were placed 
at a vacuum chamber for the sample to be submersed and the fixative can act. Eppendorf tubes 
were left overnight at 4ºC. The next day, three washes with PBS 1x were made; 30 minutes 
each at 4ºC. Samples were kept at 4ºC until they were processed. 
 
2.4.2 Medicago truncatula Plant Tissue Preparation 
 
This procedure was done using a freeze substitution and progressive lowering of 
temperature Leica EM AFS2 embedding system. In the first day, the AFS apparatus was filled 
with liquid nitrogen. In the chamber of EM AFS2 three sample containers were placed with 
plastic capsules where the samples were added together with 30% methanol. The AFS system 
was programmed for sample dehydration on the first day as described in the following table. 
 
Table 2.4.2.1 – Leica EM AFS2 First Day Setting. 
 
Temperature (ºC) Time Solution 
0 2 h 30% methanol 
-15 2 h 50% methanol 
-30 2 h 70% methanol 
-30 Overnight 100% methanol 
A 
!
B 
!
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The next day, EM AFS2 was programmed for substitution of the methanol by the 
embedding resin Lowicryl, as shown in the table 2.4.2.1. 
 
 
Table 2.4.2.2 – Leica EM AFS2 Second Day Setting. 
 
Temperature (ºC) Time Solution 
-30 30 min 75% methanol/25% Lowicryl 
-30 1 h 50% methanol/50% Lowicryl 
-30 1 h 25% methanol/75% Lowicryl 
-30 1 h 100% Lowicryl 
-30 Overnight 100% Lowicryl 
 
 
The third and the fourth day, EM AFS2 was programmed for the embedding sample in the 
Lowicryl resin, as shown in the next table. In every step, old resin was replaced with a freshly 
made one. 
 
 
Table 2.4.2.3 – Leica EM AFS2 Third and Fourth Day Setting. 
 
Temperature (ºC) Time Solution 
-30 4 h 100% Lowicryl 
-30 4 h 100% Lowicryl 
-30 Overnight 100% Lowicryl 
-30 4 h 100% Lowicryl 
-30 4 h 100% Lowicryl 
-30 Overnight 100% Lowicryl 
 
 
The fifth day, EM AFS2 was programmed for resin polymerization and, therefore new 
Lowicryl resin was freshly prepared. In new sample containers, gelatin capsules were added 
and 6 drops of freshly prepared resin were added to each capsule. With a specimen carrier-
detaching tool, plastic capsules were inserted into gelatin capsules. The sample containers 
were filled with 15 mL of ethanol in order to prevent overheating of the sample. EM AFS2 was 
programmed as described in the following table. 
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Table 2.4.2.4 – Leica EM AFS2 Fifth Day Setting. 
 
Temperature (ºC) Time 
-30 64 h 
0 3 h 
11 1 h 
22 48 h 
 
 
A LED-based UV lamp lid was placed on top of the capsules and turned on until the 
program ended. Then, capsules were released and placed in the sunlight for 24 hours for 
finishing the polymerization process. 
 
2.4.3 Medicago truncatula Plant Tissue Sectioning 
 
Plant tissue sections must be analyzed first by optic microscopy in order to decide whether 
the tissue is in good conditions to proceed to electron microscopy analysis. These first sections 
are made using a glassknife made from cutting a glass bar (previously washed with soap, 
ethanol and distilled water, always with gloves, so the hand grease is not transferred to the bar) 
in a glass knifemaker (Leica EM KMR2, Germany). Then, in an ultramicrotome (Leica EM UC6, 
Germany), the tissue embedded in Lowicryl resin was sectioned in slices of 100 nm with the 
glassknife. Finally, the tissue section was dyed with toluidine blue (colors cell walls, cytoplasm 
and nucleus) and observed under a Nikon Eclipse E1000 light microscope. If the tissue section 
seems well fixated and embedded, the sectioning will be carried out for observation under the 
electron microscope. In this case, a Diatome 45º diamond knife is used to cut 100 nm sections 
in the ultramicrotome. Tissue sections are placed in grids and left to dry. 
 
 
Figure 2.4.3.1 – Ultramicrotome Leica EM UC6 (A) and Glass Knife maker Leica EM KMR2 (B). 
 
A B 
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2.4.4 Immunodetection of Recombinant L-PGDS in Medicago truncatula Plant Tissue 
 
A piece of parafilm was cut with 10 cm length and 5 cm wide and wells were made using 
the back of a pencil (as shown in figure 4.4.1). Parafilm was placed in a squared Petri dish as 
well as a wet piece of paper to create a wet chamber. In each line of wells of the parafilm some 
drops of each reagent were placed. Thus, the grids with the sections made earlier were 
transferred from a drop to another. First the grids were placed in miliQ water for 3 minutes, 
followed by 3 minutes in autoclaved PBS 1x. For blocking unspecific reactions, grids were 
transferred to drops of 5% BSA in PBS 1x for 15 minutes. Then, grids were dried using filter 
paper before being transferred to anti – L-PGDS primary antibody (1/10) drops diluted in 1% 
BSA for 3 hours at 25ºC. Following the 3 hours of primary antibody incubation, grids were 
placed in drops of PBS 1x for washing, 6 washes of 5 minutes each. Grids were then dried with 
filter paper before being placed in anti–rabbit 10 nm gold particle secondary antibody (BB 
International, UK), diluted at 1/25 with 1% BSA. Secondary antibody incubation was performed 
for 1 hour at 25ºC. Grids were washed again with PBS 1x, 6 washes of 5 minutes each, and 
then placed in drops of PBS 1x and 2% glutaraldehyde for 10 minutes. Finally, grids were 
washed for 5 minutes in PBS 1x and then washed two times for 5 minutes in miliQ water. Grids 
were left to dry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4.4.1 – Immunolocalization scheme. 
 
 
Then, the sections in the grids have to be counterstained with 0,5% uranyl acetate (Electron 
Microscopy Sciences, USA) and lead citrate solution (Electron Microscopy Sciences, USA; see 
chapter 6.1) to increase the sample contrast when seen on electron microscope. The scheme 
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used to do this final procedure was the same for immunodetection. First, grids were placed in 
drops of uranyl acetate for 10 minutes, followed by twelve washes with miliQ water. Then, grids 
were transferred to lead citrate solution for 10 minutes and finally washed twelve times with 
miliQ water. Grids were stored at room temperature. Samples were visualized under an electron 
microscope (Philips CM10, The Netherlands) and photos taken with a CCD camera (Gattan, 
UK). 
 
2.5 Electron Microscopy analysis of Medicago truncatula Tissue Structure and 
Recombinant Protein Deposition Pattern  
 
The work that will be described here was developed at the Cellular Biology Lab at Instituto 
de Conservación y Mejora de la Agrodeversidad Valenciana, Universidad Politécnica de 
Valéncia, under the supervision of Dr José Maria Simarro, from March to June 2012. 
 
2.5.1 Fixation of Plant Material 
 
3 mL of Karnosvky were transferred to a Petri dish that had been previously placed in ice. 
The sample was placed in the fixative and cut in small pieces. With a brush, samples were 
transferred to an eppendorf with fresh fixative. When the samples did not settle in the bottom of 
the eppendorf, they were placed in a vacuum chamber for some minutes until they are totally 
submersed. Then, samples were left at room temperature for 3 hours, after which the fixative 
was replaced for a freshly prepared one and the samples were left at 4ºC overnight. The 
following day, samples were washed with 0,025M cacodylate and 1% sucrose three times for 30 
minutes each. Then, osmium solution was added and eppendorfs were placed at 4ºC for 5 
hours. This step improves fixation, since it avoids lipid extraction. The membranes become 
more permeable and, therefore, the osmotic changes do not affect the cell for the following 
process. This osmium solution also acts as a contrast agent in proteins, nucleic acids and in 
membrane polar lipids, allowing the visualization of the biologic membranes. 
 
2.5.2 Plant Tissue Preparation for EM Analysis 
 
The samples were processed using an Electron Microscopy Tissue Processing apparatus 
Leica EM TP. On a sheet of paper, the several samples to process were distributed in the eight 
compartments of each basket as shown in figure 6.4.2.1, for easy identification of the samples 
after inclusion. The baskets were distributed in the wells of the flat baskets and a solution of 
30% ethanol was transferred to the baskets. Samples were placed in each division of the 
basket. With a spike, the different baskets were put together, starting with basket no.1 and 
ending with basket no.7. Finally, baskets were tightened together with an aluminum lid with the 
help of a basket stem assembly and placed in a vial with 30% ethanol and finally transferred to 
the Leica apparatus. Here, the ethanol solution was replaced by epon resin. 
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Figure 2.5.2.1 – Loading plate scheme. 
 
The Leica apparatus was programmed as described in the following table.  
 
 
Table 2.5.2.1 – Epon resin embedding program. 
Solution Temperature (ºC) Time Objective 
30% Ethanol 4 30 min 
50% Ethanol 4 30 min 
70% Ethanol 4 Overnight 
Dehydration 
70% Ethanol + 1% 
Uranyl Acetate 
4 2 h 
Dehydration + TEM 
contrast 
90% Ethanol 4 10 min 
96% Ethanol 4 30 min 
100% Ethanol 4 2 x 1 h 
Dehydration 
100% Ethanol 3:1 
Epon 
4 3 h 
100% Ethanol 1:1 
Epon 
4 Overnight, stirring 
100% Ethanol 1:3 
Epon 
4 3 h, stirring 
100% Epon 4 Overnight, stirring 
100% Epon 4 3 h, stirring 
100% Epon 4 Overnight, stirring 
Infiltration 
 35 2 h Remove moisture 
 
 Fresh epon resin was prepared and added to gelatin capsules (one capsule per sample). 
After two hours in the incubator at 35ºC, samples were transferred from the baskets to the 
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gelatin capsules with fresh resin. Finally, gelatin capsules were placed in a incubator for 24 
hours at 60ºC to initiate resin polymerization. 
 
2.5.3 Plant Tissue Sectioning and Observation under EM 
The sectioning of the tissue embedded with epon resin was carried out in the same way as 
for lowicryl resin (see chapter 4.3). Then, grids were observed under the electron microscope 
(Philips CM10, The Netherlands). 
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3 Results and Discussion 
!
3.1 Protein Expression Level Analysis 
!
3.1.1 Leaf and Root L-PGDS Protein Extraction Analysis 
 
From plants fully-grown, leaf and root extractions were prepared as mentioned in materials 
and methods with the purpose of analyzing the expression of L-PGDS in these two tissues. 
After the extraction, the samples were applied in an SDS-PAGE gel, which separates proteins 
according to their electrophoretic mobility. The results of this procedure are shown in the 
following figures. 
 
Figure 3.1.1.1 – Leaf and Root L-PGDS Protein Extraction Analysis. SDS-PAGE (A) and Western blotting 
(B) of leaf and root protein extractions. Lane 1 and 7 – Marker Low Range BIO-RAD, lane 2 – transgenic 
Root, lane 3 - WT root, lane 4 – transgenic Leaf from plants in pots, lane 5 – transgenic leaf from in vitro 
plants, lane 6 – WT leaf. 
 
The SDS-PAGE electrophoresis gel was prepared as described in materials and methods, 
chapter 2.2. 
The sample volume loaded in the gel was different for the two samples: root and leaf. For 
leaf samples 20 µL were loaded and for root samples 10 µL.  
In the electrophoresis gel, the lanes 4, 5 and 6 corresponding to the leaves, present a 
protein distribution characteristic of leaves, with a strong band corresponding to rubisco, in 
contrast to the root lanes (2 and 3), where this protein is not present. In the root sample, the 
bands in different lanes are of the same intensity showing that the amount of protein in each 
sample was similar. In contrast, the leaf sample lanes are of different intensity due to different 
protein concentration in each sample. 
On the nitrocellulose membrane, lane 2 presents a single band with the molecular weight 
expected for L-PGDS protein (≈ 26 kDa), showing that in the root tissue, probably, there is a 
single glycoform of this protein. Regarding lane 3, Medicago truncatula wild type root, there is 
no visible signal, confirming that the primary antibody is specific for the recombinant protein in 
study and that the L-PGDS band in lane 2 is specific to the transformed tissue, since there are 
MW 
(kDa) 
104,2 
94,6 
51,7 
36,8 
28,5 
19,5 
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no unspecific reactions of the antibody to the protein. Leaf lanes 4 and 5 present an intense 
band with the molecular weight expected for the L-PGDS around 26 and 29 kDa, in contrast 
with the wild type lane, lane 6, which does not present any band. When comparing root and leaf 
bands, we can conclude that the root tissue sample is more homogeneous than leaf tissue 
sample since it only presents a single band. 
There are several studies comparing the expression of a given protein in different plant 
organs. For example, in 2006, Drakakaki and colleagues studied the expression of heterologous 
phytase in Oryza sativa in leaf and seed tissues. They also observed by Western blotting that 
the resulting bands were different between the tissues. In the nitrocellulose membrane is it clear 
that leaf and seed tissue bands differed in molecular weight. Seed sample resulted on a single 
blurred band (65 kDa) and, in contrast, the leaf sample presented two bands corresponding to 
two forms of the recombinant protein with two different molecular weights (65 and 75 kDa) 
(Drakakaki et al., 2006). In 2008, Abranches and colleagues also studied the expression of 
phytase in leaf and seed tissues, but using the plant model Medicago truncatula. Their 
observations showed that phytase expressed in seed showed a single blurred band with 65 kDa 
and when expressed in leaves the nitrocellulose membrane showed a double band with 65-70 
kDa (Abranches et al., 2008). These differences of expression of a recombinant protein in 
different plant organs shows that for each protein, the expression differs between the organ 
where it is expressed and, for different proteins, the pattern of expression in different organs 
also differs. 
 
3.1.2 Seed L-PGDS Protein Extraction Analysis 
 
The plants from which seeds would be removed to proceed to protein analysis died, so 
seed protein analysis was performed using dried stored seeds. The SDS-PAGE gel and the 
western blotting were performed as described in the materials and methods section 2.2. The 
sample volume loaded in the SDS-PAGE gel was 25 µL. 
 
 
Figure 3.1.2.1 – Seed L-PGDS Protein Extraction Analysis. SDS-PAGE (A) and Western blotting (B) of 
seed protein extractions. Lane 1 – Marker Low Range BIO-RAD, lane 2 – transgenic Seed. 
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The SDS-PAGE gel bands are very intense due to a higher concentration of proteins 
extracted. On the nitrocellulose membrane, it is possible to notice a blurred band of low intensity 
with the expected molecular weight for L-PGDS (26kDa). The low intensity of the band is 
probably due to the fact that the seeds used for the protein analysis were a mixture of first 
generation transgenic seeds, including both transformed and non-transformed seeds. Future 
work will be carried out using seeds from a tested transformed plant in order to obtain more 
conclusive results. 
 
3.1.3 L-PGDS Protein Extraction Analysis from Cell Culture Medium 
 
1,5 mL of cell culture medium was removed from the erlenmeyer one month after the 
suspension culture was established. Then, using the procedures mentioned earlier, the 
expression of L-PGDS in this system was analyzed. 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.3.1 – Western Blotting of Cell Medium Protein Extraction. Lane 1 – Marker Low Range BIO-
RAD, lane 2 – transgenic Cell Medium, lane 3 – wild type Cell Medium. 
 
 
The western blotting was prepared as described in materials and methods section 2.2. 
The sample was concentrated 20 times and the volume loaded in the SDS-PAGE gel was 25 
µL.  
It is possible to notice a blurred band around 28 to 36 kDa of molecular weight, which is 
higher than what was expected (26kDa). It is also possible to notice a higher molecular weight 
band of approximately 52 kDa, which is almost the double weight of the lower band, suspecting 
of a dimmer formation. However, L-PGDS is described in the literature as a monomer (Urade & 
Hayaishi, 2000) and the only PGDS described in the literature as a dimer is the hematopoietic 
PGDS (H-PGDS) (Urade et al., 2006). 
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3.2 L-PGDS Subcellular Deposition Analysis by Fluorescence Microscopy 
!
Subcellular deposition of each plant tissue was analyzed by sectioning fixed tissues using a 
vibratome, as described previously, and submitting them to a fluorescence immunodetection. 
The purpose for the process is to understand where the protein L-PGDS accumulates in the 
different tissues. To achieve this, for each tissue three histological sections were obtained, one 
from wild type plants and two from transformed plants, applying the specific primary antibody to 
only one of the sections of the transformed plant. This way, it will be possible to deduce if the 
primary antibody is specific for L-PGDS and if the signal of the transformed tissue treated with 
the primary antibody is in fact indicating the presence of the protein L-PGDS and not any other 
protein. Results for each tissue are depicted in the following figures. 
 
3.2.1 Analysis of Protein Deposition Patterns in the Leaf Tissue 
!
!
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.1.1 – Analysis of Protein Deposition Patterns in the Leaf Tissue. Wild type leaf with primary and 
secondary (A), transgenic leaf without primary antibody and with secondary antibody (B) and transgenic 
leaf with primary and secondary antibody (C); red – L-PGDS protein; blue – DAPI. Figures A and B were 
taken with a Leica DMRB Fluorescence Microscope and figure C with Leica SP5 Confocal Microscope. 
Scale bar = 15 µm. 
 
 
The images presented in the figure above were obtained as described in materials and 
methods chapter 2.3. Samples analyzed by fluorescence microscopy were prepared in two 
groups: wild type and transformed plants treated with L-PGDS specific primary antibody and the 
other group did not receive primary antibody treatment to serve as a negative control. 
By analysis of figure 3.2.1.1 it is possible to infer that the primary antibody is specific for the 
protein under study since the figure corresponding to wild type leaf (A) and the figure 
corresponding to transgenic leaf without primary antibody (B) present only a background, non-
specific, red signal. In figure C it is possible to visualize the antibody signal in red, showing that 
the L-PGDS protein is being accumulated in the apoplast of the leaf cells. DAPI allows 
visualization of the cell nucleus.  
A B C 
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Comparing with figure 3.1.1.1 A and B lanes 4 to 6, it is possible to deduce that, in leaf 
tissue, the recombinant protein only accumulates in the apoplast and, probably, in only one 
glycoform, since in the nitrocellulose membrane (B) it is possible to see only one intense band. 
In 2001, Peeters and colleagues observed that a Fab fragment was targeted for secretion 
and accumulated in the apoplast in Arabidopsis thaliana, when a signal for retention was absent 
(Peeters et al., 2001). In 2004, Arcalis and colleagues, studied the accumulation of phytase in 
wheat plants, observing that in the absence of any targeting signal, the recombinant protein 
accumulated in protein bodies inside the cell, in contrast with what Peeters and we observed 
(Arcalis et al., 2004). 
By analyzing these studies we can conclude that accumulation of a certain recombinant 
protein can vary due to plant species used in the study (every plant species has its particularity 
so recombinant protein accumulation can vary), the recombinant protein itself, and the plant 
organ where it is expressed. 
 
3.2.2 Analysis of Protein Deposition Patterns in the Root Tissue 
!
!
 
 
Figure 3.2.2.1 – Analysis of Protein Deposition Patterns in the Root Tissue. Wild type root with primary 
and secondary antibody (A), transgenic root without primary antibody and with secondary antibody (B) and 
transgenic root with primary and secondary antibody (C); red – L-PGDS protein and blue – DAPI. Figures 
A and B were taken in Leica DMRB Fluorescence Microscope and figure C with Leica SP5 Confocal 
Microscope. Scale Bar = 15 µm (A and C) and 10 µm (B). 
 
 
The images above were obtained as described in materials and method section 2.3. The 
root samples were prepared also in two groups as described for the leaf samples. 
As for figure 3.2.1.1 is also possible to infer that the primary antibody is specific for the 
protein under study in the root tissue, since figures A and B do not show any signal, only 
A B C 
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background. By analysis of figure C it is possible to deduce that L-PGDS accumulates in the 
apoplast, probably in the form of vesicles, since it is possible to visualize the signal in the form 
of dots. In 2001, Peeters and colleagues also observed that the Fab fragment that they were 
studying accumulated in the apoplast of Arabidopsis thaliana roots (Peeters et al., 2001). 
However, the dot pattern observed in Medicago truncatula root apoplast is not observed in 
Peeters’ study. 
Comparing figure 3.2.2.1 with the figure 3.1.1.1, lanes 2 and 3, it can be deduced that, as 
for leaf tissue, the protein accumulates in the apoplast and, probably, has only one glycoform 
since there is only one band in figure 3.1.1.1 B. This band is well defined suggesting that the 
recombinant protein produced in the root is very homogeneous, most likely with only one 
glycoform. 
 
3.2.3 Analysis of Protein Deposition Patterns in the Seed Tissue 
!
!
!
!
!
!
!
!
!
!
!
 
 
Figure 3.2.3.1 – Analysis of Protein Deposition Patterns in the Seed Tissue. Wild type seed with primary 
and secondary antibody (A), transgenic seed without primary antibody and with secondary antibody(B) and 
transgenic seed with primary and secondary antibody (C); red – L-PGDS protein and blue – DAPI. Figures 
were acquired using a Leica DMRB Fluorescence Microscope. Scale bar = 15 µm. 
 
The images above were obtained as described in the material and methods chapter 2.3. 
The seed samples were prepared also in two groups as described for the leaf samples. 
By observing images A and B of figure 3.2.3.1 it is possible to deduce that the primary 
antibody is specific for L-PGDS protein. The pattern observed in the transformed seed (C) is not 
obvious, but It seems that the protein accumulates outside the cell. Drakakaki and Abranches 
also studied the deposition pattern by fluorescence microscopy of phytase in rice and in 
Medicago truncatula, respectively. Drakakaki observed that phytase accumulated in the protein 
storage vacuoles in the rice endosperm (Drakakaki et al., 2006) and Abranches noticed that the 
phytase signaled to the secretory pathway was accumulating in the apoplast of cotyledon cells 
(Abranches et al., 2008). These observations suggest that, once more, the intracellular fate of a 
certain protein depends on the plant where it is produced. 
B C A 
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When comparing these images with the western blotting in the section 3.1.2 (figure 3.1.2.1) 
there is not a clear correspondence because different accumulation sites would correspond to 
multiple bands. Besides a glycoform analysis, it would be useful to observe seed sections under 
the electron microscope in order to understand where the protein localizes exactly. 
 
3.2.4 Analysis of Protein Deposition Patterns in the Cultured Cells 
!
!
 
 
Figure 3.2.4.1 – Analysis of Protein Deposition Patterns in the Cultured Cells. Wild type cell with primary 
and secondary antibody (A), transgenic cell without primary antibody and with secondary antibody (B) and 
transgenic cell with primary and secondary antibody (C); red – recombinant protein; blue – DAPI. Figures 
A and B were acquired with a Leica DMRB Fluorescence Microscope and figure C with Leica SP5 
Confocal Microscope. Scale bar = 15 µm. 
 
 
The images above were obtained as described in chapter 2.3, material and methods. 
Once more it is possible to observe that the primary antibody is specific for the L-PGDS 
protein. The pattern observed in the image C is totally different from any other observed, being 
similar with little dots. Probably the protein is being accumulated in small vesicles until it is 
secreted from the cell to the medium. When these images are compared with the nitrocellulose 
membrane in section 3.1.3 (figure 3.1.3.1) there is not a match for the protein band detected 
(28,5 kDa) since it seems to be several possible localizations of the protein in the cell. To better 
understand these patterns, it would help to perform a glycoform analysis and to observe these 
cells under the electron microscope, in order to understand if the protein is accumulating in 
vesicles or other structures. 
 
3.3 Subcellular Deposition Analysis of L-PGDS by Electron Microscopy 
!
Protein deposition of leaf and root tissues was analyzed by sectioning fixed embedded 
tissues with an ultramicrotome, as described above, and submitting them to immunodetection 
with 10nm gold particles. The purpose of this procedure is to understand where the protein L-
PGDS is accumulating in the cell. To accomplish this, for each tissue two histological sections 
were obtained, one from the wild type plant and the other one from the transformed plant, 
followed by application of the anti - L-PGDS primary antibody and the secondary antibody with 
A B C 
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gold particles. In this way, it will be possible to see where the protein is accumulating with great 
detail by observation of the gold particles on the tissue 
The EM work described in this chapter was developed in the Cellular Biology Lab in the 
Instituto de Conservación y Mejora de la Agrodeversidad Valenciana (Valencia, Spain), under 
the INTERBIO’s exchange program. 
Results for each tissue are depicted in the following figures. 
 
3.3.1 Analysis of Protein Deposition Patterns in the Leaf Tissue 
!
!
 
 
Figure 3.3.1.1 – Analysis of Protein Deposition Patterns in the Leaf Tissue. Wild type leaf (A) and 
transformed leaf (B) observed under the electron microscope labeled with anti – L-PGDS primary antibody 
and secondary antibody with 10nm gold particles. Scale bars = 500 nm. (See Appendix II for detail) 
 
 
The images above were obtained as described in the material and methods chapter 2.4.  
By the analysis of these pictures it is possible to see that the wild type is clear of any gold 
particle signal and that the L-PGDS protein is highly accumulated in the apoplast of the 
transformed tissue. When comparing these images with the images obtained with the 
fluorescence microscopy it is possible to observe that the deposition pattern is the same, and 
the microscopy techniques complement each other. The use of these two techniques allowed 
the confirmation that the L-PGDS protein accumulated in the leaf apoplast, as expected. 
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3.3.2 Analysis of Protein Deposition Patterns in the Root Tissue 
!
!
 
 
Figure 3.3.2.1 – Analysis of Protein Deposition Patterns in the Root Tissue. Wild type root (A) and 
transformed root (B) observed under the electron microscope labeled with anti – L-PGDS primary antibody 
and secondary antibody with 10nm gold particles. Scale bars = 500 nm. (See Appendix II for better detail) 
 
 
The images above were obtained as described in materials and methods section 2.4. 
By the analysis of these pictures it is possible to see that the wild-type root is clear of any 
gold particle signal and that the L-PGDS protein is accumulating near the cell wall. The 
paraformaldehyde fixation is not the best fixative to ensure the original conditions of the cells, 
and thus it is not possible to observe the apoplast in these samples. Therefore, when these 
images are compared with the fluorescence microscopy ones, we can suggest that the protein 
is being accumulated in cell wall linked structures, or even in the apoplast even though this 
structure cannot be seen in these images. However, the suspicion of protein accumulation 
within small vesicles as seen under the fluorescence microscope was abandoned since no such 
structures were observed. 
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3.4 Electron Microscopy analysis of Medicago truncatula Tissue Structure and 
Recombinant Protein Deposition Pattern  
 
3.4.1 Analysis of Tissue Structure of Transformed and Wild-type Leaf 
 
 
Figure 3.4.1.1 – Structure of Medicago leaf Tissue. Transformed leaf (A) and wild-type leaf (B) in epon 
resin. Scale bars: A and B = 2000 nm. Arrow heads indicating cytoplasm unattachments from the cell wall. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!
Figure 3.4.1.2 – Observation of Protein Deposition Pattern in Cellular Structure Studies. Transformed leaf 
in lowicryl resin labeled with anti-L-PGDS primary antibody and a secondary antibody anti-rabbit coupled 
to 10nm gold particles. Scale bar = 500 nm. Arrow head indicating cytoplasm unattachments from the cell 
wall. 
!
!
The images above were obtained as described in the material and methods chapter 2.4 and 
2.5. 
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The fixation and consequent visualization of tissue cells embedded in epon resin is 
important in order to analyze the structure of the cells and, possibly, to notice differences in the 
structure between the wild-type and the transformed cells. These differences can then be 
compared with the samples embedded in lowicryl resin and, possibly, the differences observed 
can be matched with the localization of the gold particles. The epon resin allows this type of 
study because the tissue fixation and embedding preserves the tissue much better than lowicryl 
resin. 
When analyzing images A and B (figure 3.4.1), a difference in structure between 
transformed and wild-type cells can be observed. In the transformed cell it is possible to see 
that there are parts of the cytoplasm unattached from the cell wall in a way that seems not to be 
arbitrary. This is confirmed when analyzing the wild-type cell, in which the cytoplasm and the 
cloroplast seem to be normally attached to the cell wall. Several samples of these two types of 
cells were visualized under the electron microscope and this difference in structure was 
consistently observed in all of them. 
When analysizing the figure 3.4.2, corresponding to a transformed cell of a tissue 
embedded in lowicryl resin and labeled with anti-L-PGDS primary antibody, it is worth noticing 
that, besides the detachment of the cytoplasm and cloroplast from the cell wall due to fixation, a 
protuberance in the cytoplasm and cloroplast is clear. Here, it is also possible to see a great 
quantity of gold particles accumulated in this area, suggesting that these detachments can be 
formed or caused by the accumulation of the recombinant protein L-PGDS.  
In order to confirm this hypothesis, it would be helpful to repeat the process, this time 
optimizing the tissue fixation, to be sure that these detachments are not due to poor fixation or 
poor embedding process. 
!
!
!
!
!
!
!
!
!
!
!
!
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3.4.2 Subcellular Deposition Analysis of L-PGDS by Electron Microscopy (continuation of 
chapter 3.3) 
 
 
! !
!
!
!
!
 
 
 
 
 
Figure 3.4.2.1 – Analysis of Protein Deposition Pattern in the Leaf Tissue. Transformed leaf labeled with 
anti-L-PGDS primary antibody,secondary antibody is an anti-rabbit coupled with 10nm gold particles. 
Scale bars: A =1000 nm, B and C = 2000 nm. Arrow heads indicating recombinant gold particles 
deposition. 
 
 
The images above were obtained as described in the material and methods chapter 2.4. 
During my second stay in Valencia, a different kind of fixation was tested. The tissues were 
fixed using a 4% paraformaldehyde solution and, instead of incubating the tissues in this 
solution directly at 4ºC overnight, the incubation started at room temperature for 5 hours and 
then overnight at 4ºC. The results achieved with this change in the fixation procedure showed to 
improve the integrity of the cell components. The improvement of the tissue quality seems to be 
crucial to the visualization of the gold particles. Labeling was performed using anti-L-PGDS 
primary antibody (1:100) and a secondary anti-rabbit antibody with 10 nm gold particles. In 
figure 3.4.1.1 there is a considerable amount of gold particles located near the xylem. The gold 
particles accumulate in the intercellular spaces as also as between the cell wall and the 
tracheids. 
A B 
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This unexpected subcellular localization might be due to several factors. One is that if the 
recombinant protein is detected in the leaf xylem, it could possibly be transported from the root 
to the rest of the plant, since this kind of transport is the major function of the vessel tissue. The 
presence of the L-PGDS protein in the root tissue is verified by the results of both western blot 
and fluorescence microscopy. Another fact worth to be noticed is that the tracheids are known 
to be conductive cells, which might explain the presence of gold labeling around these 
structures. Furthermore, xylem parenchyma cells can be modified to become transfer cells 
(characteristic of phloem), a type of cells which presents cell wall ingrowths that increase the 
surface area of the plasma membrane, thus increasing the solute transfer across the membrane 
(Taiz & Zeiger, 1991). This type of cells probably serves to retrieve or/and reroute solutes that 
move through the xylem. So, the recombinant protein can be somehow accumulated in this site 
to be redirected to another location (intracellular spaces, apoplast). Another possible 
explanation is the function of the phloem companion cells. These cells are thought to take over 
some metabolic functions like the protein synthesis, since this function is reduced or lost during 
the differentiation of the sieve elements (Taiz & Zeiger, 1991). Thus, companion cells may be 
producing the recombinant L-PGDS and, once xylem and phloem are very close together, the 
protein may be accumulating near these tissues for this reason (Taiz & Zeiger,1991). 
To better understand better this issue, it would be useful to use electron microcopy to 
analyze the subcellular localization of the recombinant L-PGDS in the xylem and phloem of the 
root tissue. 
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4 Conclusions and Future Perspectives 
 
This master thesis project aimed at studying the subcellular localization of a human protein 
with a complex glycosylation pattern, named Prostaglandin D2 Synthase lipocalin type (L-
PGDS), in a model plant species. This protein is the most abundant in the cerebrospinal fluid 
and has several important roles in physiological and pathological human functions, so its 
absence can result in several diseases. 
Medicago truncatula, the model plant species for the legume family used in this study, is 
easy to transform and manipulate in the lab and its genome is totally sequenced. Thus, it is 
being used in the lab for studies involving Molecular Farming. Since Molecular Farming seems 
a good alternative to the systems used nowadays and this protein production is important in 
terms of therapeutics, the study of its expression in plants seems an interesting challenge. 
Therefore, the work developed in this thesis is a novelty since the expression of L-PGDS in 
a plant tissue or cell has never been reported. To perform this study, plants and suspension 
cultures expressing L-PGDS in the secreted form were used. Leaves, roots, seeds of M. 
truncatula and liquid medium from the M. truncatula suspension cell cultures were analyzed by 
SDS-PAGE electrophoresis in order to determine the presence of the protein. Roots and seeds 
expressed L-PGDS with a molecular weight of 26 kDa, as expected for this protein. In leaves 
and cell medium a range of molecular weights were detected, 26-29 kDa and 28,5-36 kDa, 
respectively. This can be due to the presence of more than one glycoform of the protein in these 
cells. Nevertheless, the signal obtained in the blotting membrane for the cell medium was very 
inconsistent throughout extractions obtained at different time points. Thus, the level of protein 
expression and the growth of the cell cultures have first to stabilize for a more conclusive study 
to be carried out. 
When comparing the results obtained by SDS-PAGE electrophoresis and Western Blotting, 
the presence of only one glycoform in roots and seeds would be an advantage when compared 
to leaves and cell medium, once protein homogeneity is one of the principal requirements for its 
approval for therapeutic applications. 
The study of the protein trafficking and subcellular localization is important to determine if it 
is possible to obtain functional and non-imunogenic proteins and it is also crucial for economical 
reasons since the location where the protein is accumulating within the cell will dictate the 
downstream processes needed for obtaining the recombinant protein. The secreted form of 
recombinant proteins seems to be the more viable economically, both in plant systems and in 
cell cultures, since there is no need to proceed to a total disruption of the tissue or the cell. 
In this work, immunolocalization studies of the secreted form of L-PGDS, expressed in the 
whole plant system and in the suspension cell cultures, were performed using fluorescence and 
electron microscopy.  
In the fluorescence microscopy studies, L-PGDS was found accumulating in the apoplast 
and in structures linked to the cell wall of leaves and roots; in the roots it seemed that the 
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protein was aggregated in small vesicles. In the seeds, the pattern was not obvious but it 
tended to accumulate in the apoplast and within the cell. In the suspension cells the 
recombinant protein deposition pattern was not clear but it appears to accumulate within the 
cell, maybe in small vesicles, until it is secreted to the cell medium. Future work with the 
fluorescence microscopy technique would involve a more detailed study of the protein 
accumulation by simultaneously dyeing the ER or the Golgi apparatus. 
In the electron microscopy studies, L-PGDS deposition patterns were analyzed in leaves 
and roots. Seeds were not analyzed since they were not developed by the time I traveled to 
Valencia to process the samples for electron microscopy. The recombinant protein was found 
accumulating in the apoplast of leaf and root cells. Using this technique it was possible to 
confirm the results obtained by fluorescence microscopy and to exclude the possibility that L-
PGDS was accumulating in small vesicles in the roots, since no alike structures were detected. 
However, future work must be done in order to obtain a more significant protein signal. To do 
so, a more specific primary antibody has to be applied, since the one used is not sufficiently 
specific for the detail of the electron microscopy. In addition, the optimization of fixation and 
embedding processes have also to be done, since chemical fixation resulted in loss of tissue 
characteristics and a better embedding would improve the tissue section integrity. 
Hence, this project needs future work, due to its duration and to the fact that is innovative 
and, thus, the results obtained are preliminary. 
Although plants present several advantages for the production of recombinant proteins, as 
mentioned in the introduction chapter, one of the reasons for lack of investment is the incapacity 
of totally reproducing mammalian N-glycosylation. Glycoproteins produced in plants do not have 
β(1,4) galactose and sialic acid, and present two residues that do not exist in mammalian 
proteins, β(1,2) xylose and α(1,3) fucose. The management of these residues is very important 
for the protein functionality, so it is critical to modify the N-glycosylation pathway in a way that 
eliminates the immunogenicity caused by non-mammalian residues. 
Since this protein is a secreted form, it should contain N-glycans of the complex type 
(containing immunogenic residues like α (1,2) fucose and β (1,3) xylose), it is necessary to 
purify the protein to assess, by mass spectrometry, which glycoforms are present in each tissue 
as well as understanding which glycosylation patterns are present. With this information it will 
be possible to optimize the N-glycan humanization strategies, for example to include the 
addition of sialic acid linked to a galactose residue as described in the introduction section 
1.6.1. Besides that, N-glycosylation pathway in Medicago truncatula has also to be further 
investigated so changes in the pathway can be made to adapt it to the transformations needed 
in the protein. Thus, each case is unique since the characteristics of the final protein will depend 
on the protein and on the plant that it is being produced, in which tissue it accumulates and 
even in what compartment of the plant cell (Abranches et al., 2008; Drakakaki et al., 2006). 
Future work would also involve analyzing the differences in the structure, biochemical 
properties and stability of the final product when compared with the native form of the protein. It 
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would also be important to analyze the enzyme activity, assessing its activity by testing the 
substrate conversion rate in vivo. 
The results presented in this work showed that whole-plant systems and suspensions cell 
cultures of Medicago truncatula are promising as a Molecular Farming platform, although some 
optimizations are needed. When comparing whole plant system with plant cell cultures for the 
production of L-PGDS, each has its own advantages and disadvantages, as discussed in the 
introduction. Regarding the production in the different organs of the plant the fluorescence 
signal visualized by microscopy analysis was consistent with the western blotting analysis while 
fluorescence signal of cultured cells was not conclusive with the western blotting analysis, once 
it is very difficult to detect a protein signal without sample concentration. In addition, the protein 
under study accumulates mainly in the apoplast and cell wall (leaf and root), being easier to 
extract the protein for purification if needed than when it accumulates inside the cell. 
Despite the fact that obtaining the protein is easier in a cell culture suspension system, 
since the protein is secreted and it is only necessary to process the cell medium, the whole-
plant system seems to be more advantageous once it suggests that the protein production is 
higher. 
This master thesis can fit as groundwork for future investigations in this field, in order to 
establish effective plant systems for Molecular Farming. 
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6 Appendix 
 
6.1 Reagents and Solutions 
 
Fixation Solution: 
 
4% of Paraformaldehyde (Merck, USA) in MTSB 
 
4g of paraformaldehyde are added to 50 mL distilled water. The solution is heated at 60ºC for 
15 minutes on a heat-stir (heat-stir SB162, Stuart, United Kingdom), stirring, and 1 drop of 
NaOH (Panreac, Spain) 1M is added. Then the solution was left to cool down in a hotte and 50 
mL 2X MTSB was added. The solution is unstable so it has to be prepared just before use. 
 
Stacking Gel Buffer Stock: 
 
0.5 M Tris-HCl (pH 6.8) 
 
Tris – Base (Promega, USA) is dissolved in distilled water. Then, the pH is adjusted with HCl 
1M in a pH meter (pH meter Basic 20, Crison, Spain) to 6.8 and distilled water is added to the 
final volume. The solution is stored at 4ºC 
 
Resolving Buffer Stock: 
 
3 M Tris-HCl (pH 8.8) 
 
Tris – Base is dissolved in HCl 1M. Distilled water is added to the final volume and pH adjusted. 
The solution is stored at 4ºC. 
 
Running Buffer Stock (10x): 
 
25 mM Tris-Base 
192 mM Glycine 
0,1% SDS, pH 8.3 
 
Tris – Base, glycine are dissolved in distilled water and SDS is added. pH is adjusted to 8.3 with 
HCl 1M and the solution is stored at 4ºC. 
 
 
 
  Subcellular localization of recombinant proteins in plants 
62!
10% SDS (Sodium Dodecyl Sulphate): 
 
10 g of SDS are dissolved in 1L of distilled water. Heat up to dissolve. The solution is stored at 
room temperature. 
 
1.5% Ammonium Persulphate: 
 
0.15 g of ammonium persulphate is dissolved in 10 mL of distilled water. This solution is 
unstable so it should be made just before using it. 
 
Protein Extraction Buffer: 
 
100 mM of Ascorbic Acid 
500 mM of NaCl 
5mM of β-mercaptoethanol  
 
Ascorbic acid and NaCl are dissolved in distilled water and β-mercaptoethanol is added. pH is 
adjusted to 8.0 to NaOH 1M. The solution is stored at 4ºC. 
 
Sample Buffer 4x: 
 
0,08 M Tris-HCl pH 6.8 
2% SDS 
5% β-mercaptoethanol 
10% Glycerol 
0.001% Bromophenol Blue 
 
The final volume is completed with distilled water. The solution is stored at -20ºC. 
 
Murashing & Skoog (MS) Medium 20 x: 
 
215.1 g of MS are diluted in 5 L of distilled water. Then, the solution is transferred to 50 mL 
tubes and stored at -20ºC. 
 
Culture Medium MS Agar: 
 
30 g of Saccharose 
50 mL of Stock Solution MS 20x concentrated 
7g of Agar (Duchefa Biochemie, The Netherlands) 
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Saccharose is dissolved in distilled water and the MS 20x is added and the solution is 
transferred to Schott bottles (Schott, USA) with the Agar weighted previously, being autoclaved 
afterwards. The solution is stored at room temperature. 
 
Protein Transfer Buffer: 
 
20% Methanol 
10% Running Buffer (10x concentrated) 
 
Running buffer and methanol are diluted in distilled water. The solution is stored at room 
temperature. 
 
Phosphate buffered saline (PBS) 10x: 
 
1.36 M of NaCl 
26,9 mM of KCl 
16,8 mM of Na2HPO4 
15 mM KH2PO4  
 
The ingredients are dissolved in distilled water and pH adjusted to 7,6. The solution is stored at 
room temperature. 
 
PBS 1x: 0,1% of PBS 10x is diluted in distilled water. 
 
PBS-T: 0,1% of Tween® 20 (Sigma – Aldrich, USA) is diluted in PBS 1x. 
 
MTSB 2x: 
 
50mM PIPES 
5mM MgSO4 
5mM EGTA  
 
The solution is prepared in distilled water. NaOH is added to help dissolve the EGTA (is 
insoluble in acidic solution) and then pH is adjusted to 6.9 with dissolved H2SO4. The solution is 
stored at room temperature. 
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Tris Buffered Saline Buffer (TBS) 10x: 
 
1 M Tris-HCl pH 7.4 
5 M NaCl  
 
The ingredients are diluted in distilled water. The solution is stored at room temperature. 
 
 TBS 1x: TBS 10x is diluted in distilled water. 
 
2.5% Agar: 
 
2.5 g of agar are dissolved in 1 L of distilled water. The solution is heated up until total 
dissolution of agar. The solution is stored at room temperature. 
 
Coomassie Brilliant Blue G-250: 
 
45% Methanol (100%) 
10% Glacial Acetic Acid 
0,1% Commassie Blue 
 
The solution is stored at room temperature. 
 
Coomassie Dye De-staining Solution: 
 
45% methanol  
10% Glacial Acetic Acid  
 
Methanol and glacial acetic acid are added to distilled water. The solution is stored at room 
temperature. 
 
NBT/BCIP Buffer: 
 
0.1 M of Tris-HCl pH 9.0 
0.01 M of NaCl 
0.05 M MgCl2  
 
The ingredients are dissolved in distilled water. The solution is stored at 4ºC. 
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NBT/BCIP Detection Solution: 
 
6.6 µL of BCIP (Promega, USA) 
13.2 µL of NBT (Promega, USA)  
 
BCIP and NBT are added to NBT/BCIP Buffer, in an eppendorf covered with aluminium paper. 
This solution is prepared just before use. 
 
DAPI: 
 
DAPI stock solution (1.6 mg/mL) is diluted in distilled water to obtain the final solution (1µg/mL). 
 
Lowicryl Resin: 
 
To prepare 100 g of Lowicryl resin: 
13.5 g of Crosslinker A (Electron Microscopy Sciences, USA) 
86.5 g of Monomer B (Electron Microscopy Sciences, USA) 
0.50 g of Initiator (Electron Microscopy Sciences, USA).  
 
Stir and store at 4ºC. 
 
Uranyl Acetate Solution: 
 
0,5% uranyl acetate (Electron Microscopy Sciences, USA) are diluted in 100% methanol 
(Panreac, Spain). 
 
Lead Cytrate Solution (Reynolds Solution): 
 
Solution A: Lead Nitrate 1M 
Solution B: Trisodic Cytrate 1M 
Solution C: NaOH 1M 
Distilled water is boiled to eliminate carbon dioxide, since it precipitates lead, and 
placed in a 50 mL tube. Then, the tube is placed under cool running water. Finally, 
NaOH is added. 
 
The final solution is prepared in a 50 mL tube adding 16 mL of distilled water and 3 mL of 
solution B, stirring slowly by inversion. Then, 2 mL of solution A are added, stirring until the 
precipitate formed is totally dissolved. 4 mL of solution C are added slowly until the solution 
turns transparent, stirring by inversion ocasionally. The final solution is filtered with a syringe 
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with a filter (Whatman 0.2 µm PTFE w/GMF) to the immunodetection parafilm. The solution can 
be maintained at room temperature, in a vertical position. 
 
0,025 M Cacodylate Solution: 
 
0,025 M cacodylic acid (Electron Microscopy Sciences, USA) are added to distilled water and 
dissolved by stirring.  
pH is adjusted to 6.9 and then the solution is transferred to an 500 mL Schott bottle and stored 
at 4ºC. 
 
Karnosvky Fixative Solution: 
 
16% Paraformaldehyde (Electron Microscopy Sciences, USA) 
25% Glutaraldehyde (Electron Microscopy Sciences, USA) 
0.006M Calcium Chloride  
 
The ingredients are diluted in 0.025 M cacodylate solution. Paraformaldehyde is added as also 
as the glutaraldehyde. The calcium chloride is weighted in a different tube and diluted in 
cacodylate solution, adjusting the pH to 6.9. Then, calcium chloride solution is added to the 
paraformaldehyde and glutaraldehyde solution and stirred by inversion. The final solution is 
divided for several eppedorfs and stored at -20ºC. 
 
Osmium Solution: 
 
0.033 M Cacodylate Solution 
4% OsO4 (Electron Microscopy Sciences, USA) 
 
The final solution is divided into several eppendorfs covered with aluminium foil paper and 
placed in liquid nitrogen. When frozen, eppendorfs were stored at -20ºC. 
 
Epon Resin Preparation: 
 
Epon resin is an aliphatic hydrophobic epoxi resin. In a hotte, two solutions are prepared as 
follows. 
Solution A: 2.2 M DDSA (Electron Microscopy Sciences, USA) and 4.5 g of Epon 812-substitute 
(Electron Microscopy Sciences, USA). The solution is stirred until it became homogeneous. 
Solution B: 2.6 M NMA (Electron Microscopy Sciences, USA) and 5.5 g of Epon 812-substitute. 
The solution is stirred until it became homogeneous. 
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Then, the two solutions are mixed and 0.10 M BDMA is added, since it is an accelerator, 
favouring the polymerization. The solution is stirred slowly for 20 minutes, to avoid the formation 
of bubbles. The solution is stored in a falcon tube at 4ºC. 
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6.2 Electron Microscopy Images 
 
 
Wild-type and Transgenic Leaves 
 
 
 
Figure 6.2.1 – Analysis of Protein Deposition in the Leaf Tissue. Wild type leaf (A) and transgenic leaf (B) observed under the electron microscope. It is noticeable the 
considerable accumulation of gold particles in the cell apoplast (B). Scale bars: 500 nm. 
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Wild-type and Transgenic Roots 
 
 
 
Figure 6.2.2 – Analysis of Protein Deposition Patterns in the Root Tissue. Wild type root (A) and transgenic root (B) observed under the electron microscope Note the 
gold particles accumulating in the cell wall (B). Scale bars: 500 nm. 
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6.3 Work Presented in Congresses during the Master Thesis Development 
 
The following abstract was presented, as a poster, in the Interbio Symposium “Frontiers in 
Protein Research”, held in Oeiras, 5th to 7th May 2011. 
 
Sorting of recombinant proteins in the plant secretory pathway 
 
Rita B. Santos, Ana Cláudia Nogueira, Ana Sofia Pires, Rita Abranches 
Plant Cell Biology Laboratory, Instituto de Tecnologia Química e Biológica, UNL, Avenida da 
República, 2781-901 Oeiras, Portugal 
e-mail: ritabsantos@itqb.unl.pt 
 
Abstract: 
 
Molecular farming – the production of recombinant proteins in plants – is a promising alternative 
to microbial or animal systems for the production of high value molecules. Plant-produced 
molecules present significant reduced costs and are mainly applied to therapeutics, diagnostics 
and industrial enzymes.  
We have been using the legume plant Medicago truncatula for the production of recombinant 
proteins which are targeted to the secretory pathway and are either secreted or retained 
intracellularly. In this work, we investigated the deposition patterns of a human protein, 
prostaglandin D2 synthase lipocalin type or β-trace, in different organs of Medicago plants, to 
address the tissue specific factors that affect the successful production and accumulation of 
recombinant proteins. By using immunolabeling and fluorescence microscopy, we observed 
significant differences in subcellular deposition of the recombinant protein in leaves, seeds and 
roots, which affected glycosylation profiles and consequently the properties of the purified 
product. Understanding the plant secretory pathway is thus essential for assessing and 
optimizing plant systems for the production of human therapeutics. 
Preliminary results show different deposition patterns in leaf, root and seed, to be confirmed by 
western blotting and fluorescence microscopy. 
  Subcellular localization of recombinant proteins in plants 
71!
The following abstract was presented, as an oral presentation, in the Microscopy at the 
Frontiers of Science Congress, held in Aveiro, 18th to 21st October 2011. 
 
Microscopy analysis of recombinant protein deposition patterns in transgenic Medicago 
plants 
 
Rita B. Santos, Ana Sofia Pires, Rita Abranches 
Plant Cell Biology Laboratory, Instituto de Tecnologia Química e Biológica, UNL, Avenida da 
República, 2781-901 Oeiras, Portugal 
e-mail: ritabsantos@itqb.unl.pt 
 
Abstract: 
 
Molecular Farming – the production of recombinant proteins in plants – is a promising 
alternative to microbial or animal systems for the production of high value molecules [1]. Plant-
produced molecules present significant reduced costs and are mainly applied to therapeutics, 
diagnostics and industrial enzymes. Understanding the different pathways that a protein can 
take in a plant tissue is essential for assessing and optimizing plant systems for the production 
of human therapeutics. Microscopy is one of the most important techniques to achieve this 
knowledge, since it reveals the localization of the recombinant proteins within the plant cell, thus 
allowing to assess possibly different protein glycoforms that may be produced. This information 
is crucial to understand if the recombinant protein is suitable for human therapeutics, and also 
to devise the best procedures for purification of the recombinant product. 
We have been using the legume plant Medicago truncatula for the production of recombinant 
proteins [2], which are targeted to the secretory pathway and are either secreted or retained 
intracellularly. In this work, we investigated the deposition patterns of a human protein, 
prostaglandin D2 synthase lipocalin type or β - trace, in different organs of Medicago plants, to 
address the tissue specific factors that affect the successful production and accumulation of 
recombinant proteins. By using immunolabeling and fluorescence microscopy, we observed 
significant differences in subcellular deposition of the recombinant protein in leaves, seeds and 
roots, which affected glycosylation profiles and consequently the properties of the purified 
product. We demonstrate that microscopy is a crucial method for Molecular Farming to 
progress. 
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Figure 6.3.1 – Localization of the recombinant protein in transgenic Medicago truncatula plants by 
fluorescence microscopy. (A) leaf, (B) root, (C) seed. Blue – DAPI; Red – specific antibody for L-PGDS. 
[1] Fischer, R., Emans, N., Transgenic research, 9 (2000) 279-299. 
[2] Abranches et al. Journal of Biotechnology, 120 (2005) 121-134.  
 
 
 
 
